rfhg_240580.1

Basic information about the TSS

---

TSS ID: rfhg_240580.1 Species: human Chr: chrX		Start: 154440345 End: 154440365 Strand: +
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000471972.1:-77 GeneID: 2664 HGNC/MGI_ID: HGNC:4226 UniProt_ID: Nearer transcript ids and distances:

Gene_name: GDI1 Gene_symbol: GDI1 Gene_synonyms: FLJ41411 OPHN2 RABGDIA XAP-4 Gene_source: HGNC:4226

TATA-Box annotation

---

Distance to TSS:	3201
Nearest PromoterID:	NM_001493
Entrez ID:	2664
Nearest Unigene:	Hs.74576
Nearest Refseq:	NM_001493
Nearest Ensembl:	ENSG00000203879
Gene Name:	GDI1
Gene Alias:	1A|GDIL|MRX41|MRX48|OPHN2|RABGD1A|RABGDIA|XAP-4
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.523810
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GDI1 p2@GDI1 p3@GDI1 p4@GDI1 p5@GDI1 p6@GDI1 p7@GDI1 p8@GDI1 p9@GDI1 p10@GDI1
Sample		p1@GDI1	p2@GDI1	p3@GDI1	p4@GDI1	p5@GDI1	p6@GDI1	p7@GDI1	p8@GDI1	p9@GDI1	p10@GDI1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	14.22	8.18	7.01	4.87	0.97	1.17	1.75	0.58	0.58	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	21.45	11.53	6.27	4.65	1.01	0.81	2.02	0.40	0.00	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	18.33	11.57	6.37	7.91	0.77	0.96	1.93	0.19	0.96	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	12.89	8.73	7.07	4.37	0.42	0.21	1.46	0.62	0.62	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	16.20	12.82	6.30	4.27	0.45	1.12	0.67	0.22	0.90	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	12.21	7.17	5.81	3.88	0.19	0.78	1.94	0.97	0.58	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	28.54	14.38	5.88	6.32	0.22	0.87	2.61	0.65	0.87	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	16.96	9.20	6.78	3.63	0.00	1.45	2.42	0.48	0.48	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	18.59	14.53	5.13	5.13	0.43	0.85	1.50	0.64	0.85	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	15.07	13.91	1.16	6.38	0.58	0.58	1.16	0.58	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	12.53	15.36	3.64	4.04	0.81	1.62	0.81	0.81	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	18.29	12.20	3.25	6.50	0.81	0.41	1.63	0.81	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	20.15	3.87	2.74	1.13	0.48	0.48	2.58	1.13	0.16	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	20.75	3.76	1.35	0.90	0.60	1.05	2.26	0.30	0.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	16.47	2.85	2.63	0.88	0.44	0.22	1.76	1.32	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	19.87	3.02	1.76	1.26	0.25	1.26	3.02	0.75	1.51	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	19.44	3.71	2.18	0.44	0.22	0.44	4.15	0.66	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	15.19	1.27	3.37	0.42	1.27	0.42	3.80	0.84	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	17.06	4.27	0.00	1.07	0.00	0.53	2.13	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	16.85	3.01	1.35	0.90	0.45	1.20	3.01	0.15	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	23.92	4.28	2.54	1.20	0.27	0.80	1.74	0.67	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	21.92	4.66	2.07	0.86	0.52	0.52	3.45	0.17	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	21.84	4.27	2.59	0.78	0.13	0.52	3.62	0.78	0.65	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	19.66	3.64	3.40	0.97	0.24	0.73	3.88	0.73	0.97	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	15.74	3.87	2.58	1.03	0.00	0.77	2.58	0.26	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	24.37	3.17	2.53	0.63	0.32	0.95	1.27	0.95	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	17.03	6.59	1.65	0.55	0.00	0.00	1.65	0.55	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	22.87	4.72	2.12	1.18	0.47	0.71	3.06	1.18	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	13.73	4.04	1.78	0.48	0.48	0.48	2.91	0.81	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	18.82	3.80	2.53	2.17	0.18	0.36	3.80	0.54	1.09	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	16.12	3.98	1.47	1.67	0.42	0.63	3.77	1.05	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	16.22	4.88	1.76	1.37	0.20	0.20	2.74	0.00	0.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	17.09	3.38	2.11	1.27	0.63	1.06	2.95	0.42	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	22.93	5.77	1.32	0.66	0.99	0.82	5.44	0.66	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	13.84	1.68	0.75	0.37	0.56	1.12	3.93	0.56	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	18.01	3.64	2.11	1.15	0.38	0.77	2.30	0.00	0.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	16.55	3.27	2.45	0.82	0.20	0.41	2.04	0.61	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	15.31	2.42	1.61	0.40	0.40	1.21	2.62	0.20	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	17.56	4.05	1.62	1.62	0.27	0.00	1.89	0.00	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	16.08	3.84	2.64	1.20	0.72	0.72	1.44	0.72	1.20	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	15.76	3.53	2.82	0.47	0.47	0.47	1.18	0.71	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	16.98	3.81	0.73	0.88	0.29	0.15	3.07	0.88	0.29	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	11.18	4.22	2.53	0.42	0.21	0.63	3.59	0.00	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	13.11	2.97	1.92	1.05	0.70	0.87	2.45	0.35	0.52	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	14.46	4.42	2.41	1.00	0.20	0.60	3.01	0.00	0.40	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	15.82	2.33	1.86	1.16	0.47	1.40	3.49	0.00	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	11.52	2.40	2.16	1.92	0.24	0.00	3.36	0.72	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	12.22	3.58	0.89	1.49	0.30	0.89	3.87	0.60	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	10.53	3.35	3.11	2.63	0.24	0.24	3.11	0.96	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	13.14	4.65	2.22	0.81	0.40	0.40	1.42	0.20	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	15.99	3.48	2.66	1.84	0.20	1.02	4.10	0.41	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	13.12	3.34	2.22	2.22	0.67	1.11	2.22	1.11	0.67	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	27.98	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	11.00	1.77	2.84	2.13	0.35	0.00	2.48	1.06	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	12.26	2.32	3.65	0.99	0.33	0.66	1.66	0.33	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	20.97	5.03	1.68	1.68	0.84	3.36	20.97	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	14.24	6.43	4.13	1.38	0.46	2.30	9.64	1.38	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	8.43	3.89	2.59	1.62	0.00	0.32	1.94	1.30	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.35	1.93	4.18	2.25	0.00	0.00	0.64	0.32	1.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	15.72	7.54	3.77	0.94	0.31	1.26	9.74	0.63	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	7.76	6.35	3.53	0.71	0.00	2.12	2.12	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	11.22	5.05	1.12	1.12	1.12	1.68	1.68	0.56	0.00	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	21.50	11.15	3.18	3.18	0.00	0.00	12.74	0.00	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	11.21	7.81	2.72	0.34	1.02	0.68	6.80	0.68	1.02	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	7.15	2.92	3.25	0.65	0.32	2.60	1.95	0.97	1.95	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.71	6.39	2.84	3.19	1.42	2.48	3.55	0.71	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	64.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	71.08	31.59	7.90	7.90	0.00	23.69	31.59	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	17.06	6.83	7.31	0.98	1.95	1.46	3.41	0.98	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	16.86	6.45	3.47	0.99	0.99	0.50	1.49	0.99	2.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	16.89	5.63	4.22	1.41	0.47	0.94	2.81	2.35	1.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	15.90	7.29	1.66	0.99	0.33	1.32	2.65	2.32	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	12.99	2.17	3.40	0.93	0.93	1.55	4.95	1.55	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	13.45	5.81	4.28	2.45	0.00	1.53	1.53	1.53	0.31	0.61
Adipocyte - breast, donor1	11376-118A8	27.24	6.97	7.60	1.43	0.79	0.63	0.79	0.32	0.16	0.79
Adipocyte - breast, donor2	11327-117E4	20.21	5.45	4.97	1.93	1.44	1.93	2.41	0.32	0.96	0.48
Adipocyte - omental, donor1	11473-119C6	25.19	7.51	6.62	1.27	1.91	1.15	0.76	0.76	0.38	0.38
Adipocyte - omental, donor2	11474-119C7	17.94	8.22	6.73	1.49	2.99	0.75	1.49	1.49	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	15.07	3.68	4.35	1.00	0.67	0.33	0.67	1.00	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	11.48	6.38	4.47	1.91	0.00	0.00	1.28	1.28	0.64	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	2.20	2.20	1.10	1.10	1.10	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	19.42	4.97	5.42	1.35	0.45	0.00	0.00	0.90	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	24.15	4.34	2.43	1.22	0.00	0.35	0.35	0.17	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	24.45	4.50	4.69	2.93	0.39	0.39	0.59	0.20	0.00	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	11.84	2.06	6.43	1.54	0.51	0.26	0.00	0.77	0.26	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	15.61	2.79	4.18	1.39	0.84	0.28	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	12.93	3.53	4.70	1.76	1.18	0.00	0.59	0.59	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	22.76	3.62	5.31	1.69	0.08	0.08	0.48	0.72	0.32	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	10.01	3.23	4.84	1.29	0.32	0.32	0.97	0.32	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	9.06	2.13	2.13	0.53	1.07	0.53	0.53	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	9.46	3.34	1.67	0.56	0.00	0.56	0.56	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	10.40	1.66	2.08	2.08	0.00	0.42	0.42	0.00	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	10.80	1.51	5.78	1.26	0.25	0.75	1.00	0.50	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	6.54	2.29	4.91	1.64	0.33	0.00	0.65	0.33	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	6.39	0.61	2.74	2.13	0.30	0.30	0.00	0.30	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	29.83	15.03	11.71	4.20	1.77	0.44	0.44	0.22	0.44	2.87
Alveolar Epithelial Cells, donor2	11590-120G6	39.09	14.34	7.89	2.51	2.15	1.08	0.36	0.00	0.72	3.23
Alveolar Epithelial Cells, donor3	11671-122G6	23.96	4.79	5.99	0.00	0.00	0.00	1.20	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	21.23	5.40	5.58	2.34	0.54	0.36	0.54	0.36	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	23.43	0.00	6.69	0.00	0.00	0.00	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	22.19	4.11	7.60	3.29	0.41	0.41	0.00	0.62	0.21	0.41
Anulus Pulposus Cell, donor1	11248-116E6	29.18	3.66	3.43	0.69	1.26	0.46	0.34	0.92	0.23	0.46
Anulus Pulposus Cell, donor2	11463-119B5	21.31	3.92	2.94	1.47	0.49	0.00	0.73	0.49	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	14.83	7.19	10.78	0.90	0.45	0.45	1.35	1.80	1.80	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	26.92	9.12	6.95	3.47	0.87	0.43	2.17	0.87	2.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	12.84	2.14	12.84	2.14	2.14	2.14	4.28	6.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	20.33	13.75	7.17	2.39	2.69	0.60	1.79	0.60	1.20	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	10.12	5.06	3.79	0.00	0.00	1.26	7.59	2.53	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	15.84	6.60	9.24	1.98	1.98	2.64	0.00	1.32	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	17.22	13.97	6.82	1.95	1.62	0.65	1.95	1.30	0.32	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	23.79	8.25	12.14	2.91	3.40	1.46	0.00	2.91	0.97	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	21.38	7.13	8.91	0.59	1.19	2.38	3.56	0.59	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	18.83	10.55	6.78	0.75	1.13	1.13	2.26	1.88	0.75	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	22.50	13.79	7.26	1.45	2.90	2.90	0.73	1.45	0.00	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	16.30	6.27	7.52	3.76	1.25	0.00	2.51	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	31.46	12.52	9.55	1.81	1.98	0.33	0.33	0.49	0.00	1.32
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	6.82	5.46	0.00	1.36	2.73	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	14.78	4.67	7.24	1.96	1.06	0.00	0.30	1.06	0.15	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	19.29	8.57	5.89	3.75	0.54	0.54	1.07	0.54	1.07	3.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	19.08	9.07	7.75	2.46	1.51	0.76	0.38	0.38	0.38	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	17.37	6.15	8.82	1.34	1.07	0.00	1.60	0.27	0.27	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	11.71	10.73	5.85	1.95	0.98	3.90	0.00	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	20.07	9.29	9.29	2.82	1.82	1.33	1.33	1.33	0.50	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	25.22	9.61	7.20	1.20	3.60	0.00	0.00	1.20	2.40	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	0.00	10.62	3.54	0.00	0.00	0.00	0.00	3.54	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	21.10	10.29	8.92	1.89	1.20	1.37	0.51	0.34	0.69	1.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	0.00	0.00	4.19	0.00	4.19	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	16.99	12.14	7.77	0.00	1.46	1.94	0.49	0.00	0.97	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	29.60	10.25	9.11	1.90	1.14	0.38	2.66	1.52	0.38	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	18.17	6.06	1.21	2.42	2.42	0.00	3.63	0.00	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	19.38	7.98	10.83	1.71	1.71	1.14	0.00	1.14	0.57	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	19.67	12.40	9.41	1.50	1.92	0.21	0.86	0.64	0.64	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	17.81	5.68	11.87	1.29	0.77	1.81	1.29	0.52	0.77	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	20.18	12.20	7.04	2.35	0.94	0.47	1.41	0.47	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	22.83	11.90	7.07	2.25	1.29	0.32	1.93	1.93	0.96	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	11.42	6.42	9.99	2.14	0.71	0.71	0.71	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	19.89	5.85	10.53	1.17	3.51	2.92	0.00	0.58	1.17	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	21.68	9.94	6.02	1.81	1.51	1.20	0.60	0.30	1.20	1.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	23.76	9.50	11.88	2.38	0.00	0.00	0.00	0.00	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	26.45	10.17	9.66	1.53	0.51	1.53	1.53	1.02	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	23.94	13.24	8.15	1.53	1.78	0.51	2.29	0.51	0.25	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	20.97	4.45	8.90	0.00	1.27	1.27	3.18	1.91	1.27	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	18.12	8.20	6.47	2.59	0.43	0.86	0.43	1.73	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	24.56	7.62	8.68	2.33	1.06	0.42	0.85	0.85	1.27	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	13.05	7.83	8.99	0.58	1.16	0.00	0.58	0.87	0.29	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	18.89	12.28	7.56	1.89	2.83	1.89	0.94	1.89	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	26.11	7.80	7.97	1.53	1.53	0.34	1.53	0.51	0.17	1.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	4.63	4.63	2.32	2.32	0.00	2.32	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	19.01	4.23	4.23	2.11	0.00	0.00	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	17.15	11.58	7.50	2.79	2.14	0.64	1.07	0.86	1.07	1.29
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	13.24	5.41	10.23	2.41	0.60	0.00	1.20	0.60	0.60	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	15.31	5.83	9.48	0.00	0.73	0.73	0.73	1.46	0.00	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	25.06	10.34	9.43	3.45	2.07	1.15	2.07	0.23	0.69	1.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	5.10	5.10	2.55	0.00	0.00	2.55	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	14.75	10.42	10.17	3.05	0.51	0.51	0.51	0.76	0.25	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	24.98	13.63	9.70	1.24	1.03	0.83	1.03	1.03	0.83	1.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	19.28	7.65	8.87	1.53	1.22	0.61	1.53	1.22	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	21.03	13.38	10.99	2.39	1.43	0.48	2.39	1.91	1.43	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	22.62	9.76	9.09	2.00	1.77	1.77	1.77	1.33	0.44	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	19.84	7.63	10.68	0.00	4.58	1.53	4.58	3.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	18.28	12.74	7.20	1.66	3.32	0.00	0.00	1.11	0.00	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	22.77	9.53	9.53	3.71	2.12	2.65	1.06	1.59	0.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	23.26	8.36	9.09	2.91	1.45	1.09	1.09	1.82	0.36	1.09
Astrocyte - cerebellum, donor1	11500-119F6	50.35	20.26	10.93	3.19	4.30	1.35	0.98	1.23	0.37	1.35
Astrocyte - cerebellum, donor2	11580-120F5	51.18	16.09	9.93	4.62	2.40	1.88	1.03	1.03	1.20	1.20
Astrocyte - cerebellum, donor3	11661-122F5	45.93	17.41	6.71	3.99	2.31	1.05	0.42	0.63	0.42	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	82.61	25.45	11.50	5.23	3.83	0.70	1.74	1.74	0.35	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	52.74	22.00	17.96	7.60	2.59	2.75	1.29	2.43	1.94	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	70.70	24.46	13.72	6.56	2.83	3.13	1.79	2.39	0.89	1.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	37.62	1.83	4.36	1.95	0.34	2.18	0.57	1.03	0.57	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	35.96	2.00	4.64	1.63	0.38	1.00	1.13	0.25	0.38	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	33.68	2.84	2.96	1.82	0.57	0.68	0.46	0.68	0.80	0.00
Basophils, donor1	12241-129G9	30.08	4.71	3.14	1.83	0.00	0.26	0.78	0.26	0.00	0.52
Basophils, donor2	12242-129H1	34.28	1.80	3.97	0.72	0.00	0.36	0.72	0.00	0.00	0.36
Basophils, donor3	12243-129H2	27.19	2.79	4.26	1.62	0.00	0.29	0.29	0.29	0.15	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	17.25	4.10	5.82	2.16	0.43	0.65	0.86	0.86	0.00	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	31.55	10.52	6.86	3.20	1.37	3.20	1.37	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	12.55	5.02	5.65	1.88	0.63	0.63	0.63	0.00	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	25.37	5.20	7.90	1.04	0.42	0.42	0.00	0.42	0.00	1.66
Bronchial Epithelial Cell, donor6	11461-119B3	31.32	5.53	3.68	1.15	0.00	0.92	0.23	0.46	0.92	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	18.35	2.70	3.42	1.44	0.36	0.54	0.72	0.54	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	20.10	3.71	6.29	0.72	0.10	0.21	0.41	0.31	0.31	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	28.65	3.49	3.96	2.79	0.47	0.47	0.23	0.00	0.23	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	16.95	1.28	1.92	0.96	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	52.41	6.20	15.22	4.51	1.13	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	35.64	4.08	9.84	2.60	0.56	1.67	0.56	0.56	1.11	0.56
CD14+ Monocytes, donor3	11381-118B4	34.03	1.98	12.07	2.41	0.66	0.22	0.66	0.22	0.22	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	37.93	3.40	11.89	2.83	1.13	0.00	0.57	0.28	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	26.16	5.31	12.51	3.79	0.38	0.00	0.76	1.14	0.76	2.27
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	30.90	3.62	11.51	4.60	0.33	0.00	1.31	0.33	0.00	1.64
CD14+ monocytes - mock treated, donor1	11863-125A9	37.15	3.76	14.31	5.06	1.30	0.58	2.31	0.43	1.16	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	28.06	3.92	13.28	3.62	2.11	0.91	1.21	0.30	0.30	2.41
CD14+ monocytes - mock treated, donor3	11883-125D2	29.85	4.03	12.79	4.03	1.66	1.18	1.42	0.47	0.24	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	31.81	4.35	17.07	6.19	0.50	1.34	1.00	1.51	0.67	1.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	32.85	3.86	16.28	5.24	0.83	1.10	0.55	0.55	0.28	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	36.94	4.96	12.40	5.45	0.50	0.99	1.24	0.25	1.74	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	35.24	2.94	8.81	3.13	0.78	1.96	0.39	0.98	0.39	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	31.16	3.56	5.88	2.85	0.53	0.71	0.71	0.18	0.36	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	40.04	4.35	10.01	3.05	0.22	0.65	1.31	0.22	0.44	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	32.08	2.81	7.26	3.51	0.47	1.64	0.70	0.00	0.70	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	45.94	5.28	5.81	5.81	0.00	0.00	0.00	0.00	1.06	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	31.06	3.33	9.98	6.66	0.00	1.11	1.11	2.22	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	37.04	5.50	11.90	3.72	0.74	1.19	2.38	0.89	1.49	1.04
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	32.33	5.39	11.77	5.19	0.60	0.80	0.40	0.80	0.80	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	30.19	6.45	14.78	4.37	1.04	0.42	0.62	0.62	0.21	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	51.71	6.86	15.33	7.32	1.14	2.06	1.37	0.92	0.69	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	30.99	4.98	11.08	4.30	0.45	1.13	0.68	0.45	0.45	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	43.21	3.49	13.97	4.80	0.44	1.31	0.00	1.31	0.87	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	25.55	4.03	9.15	2.15	0.27	1.08	1.88	0.54	1.08	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	37.68	3.84	4.88	1.92	1.40	0.70	0.87	0.87	0.52	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	31.56	2.52	8.42	3.37	1.68	0.00	1.68	0.84	0.42	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	48.50	4.04	16.72	6.98	0.73	1.10	1.84	0.00	1.65	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	31.35	4.93	16.56	7.05	1.06	0.70	0.70	0.35	1.06	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	51.77	10.97	23.25	7.90	0.44	0.00	0.88	1.32	0.44	3.07
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	28.77	3.84	4.88	4.53	0.52	1.92	0.87	0.52	0.87	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	36.05	3.35	9.29	2.23	0.00	1.49	0.37	0.00	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	36.43	6.04	10.35	3.88	0.65	1.08	1.29	0.43	0.00	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	49.55	4.09	10.24	3.69	0.82	1.23	2.05	0.82	0.41	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	28.51	3.94	10.43	3.48	0.93	0.46	0.00	0.46	0.46	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	32.71	6.26	9.74	4.41	0.23	0.70	0.23	0.00	0.70	1.39
CD14+CD16+ Monocytes, donor1	11789-124B7	25.07	2.40	6.54	2.40	0.00	1.09	0.44	0.44	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	24.95	3.00	4.85	0.92	0.69	0.23	0.46	0.46	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	20.36	1.52	3.03	0.87	0.43	0.22	0.22	0.22	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	39.24	2.65	5.61	2.96	0.31	0.16	0.78	0.47	0.00	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	34.06	0.87	4.19	2.10	0.70	0.52	0.70	0.52	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	36.34	2.90	5.80	2.01	0.00	0.89	0.22	0.00	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	37.51	1.02	4.59	2.30	0.00	1.02	0.00	1.02	0.26	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	36.01	2.42	5.49	1.54	0.44	0.44	0.44	0.22	0.22	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	23.37	2.11	4.21	1.05	0.42	0.21	0.21	0.63	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	73.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	54.92	1.36	3.39	0.00	0.00	0.68	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	44.53	3.11	4.14	1.04	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	42.64	1.07	1.60	1.60	0.53	0.00	0.00	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	62.18	1.07	4.29	1.07	0.00	1.61	0.00	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	54.05	4.21	4.91	1.40	0.00	0.00	1.40	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	57.26	3.14	3.92	0.78	0.78	0.00	0.78	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	65.91	3.95	0.00	1.32	1.32	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	35.34	0.00	3.29	3.29	0.00	0.82	0.00	0.00	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	23.21	0.73	3.63	4.35	0.00	1.45	2.18	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	36.85	1.51	3.03	1.01	1.01	1.01	1.01	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	26.67	4.85	6.46	1.21	0.40	0.81	0.81	0.40	0.40	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	22.37	2.40	5.59	0.80	0.00	0.00	0.40	0.40	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	16.06	0.00	3.01	2.01	1.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	23.03	5.06	3.37	1.69	0.56	0.56	0.00	0.56	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	18.04	1.50	2.25	0.38	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	19.84	0.68	3.16	0.68	0.00	0.00	0.00	0.23	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	44.99	3.57	7.50	1.43	0.00	0.71	0.36	0.71	1.07	0.36
CD4+ T Cells, donor2	11306-117C1	49.60	4.29	5.51	1.84	0.00	0.61	1.22	0.61	2.45	0.00
CD4+ T Cells, donor3	11382-118B5	55.81	5.18	5.79	0.91	2.13	1.22	2.74	0.00	2.13	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	48.75	5.87	6.89	2.30	0.51	0.77	1.02	0.26	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	50.98	5.61	8.76	1.57	0.45	1.12	1.35	0.22	0.67	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	58.35	6.61	8.91	2.30	1.15	0.57	1.72	0.29	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	75.38	2.84	3.32	1.42	0.00	0.00	0.47	0.95	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	68.13	6.32	2.11	1.40	0.00	0.70	1.40	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	69.22	6.59	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	40.90	4.05	6.65	1.30	0.87	0.43	1.01	1.01	0.58	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	34.91	7.12	12.37	2.03	1.02	1.36	1.36	0.51	1.02	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	45.30	5.80	12.25	2.10	1.45	0.48	2.10	0.32	0.81	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	59.18	5.83	8.52	0.90	1.34	0.90	0.00	2.24	0.45	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	63.59	8.73	5.94	1.40	2.10	0.70	1.05	0.70	0.70	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	63.36	7.04	4.84	0.88	1.32	0.88	1.32	0.44	0.00	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	27.83	2.53	2.11	0.84	0.42	0.84	0.84	0.00	0.42	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	23.89	1.87	5.82	1.25	0.21	0.21	1.25	0.42	0.21	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	19.71	1.34	5.68	1.67	1.67	0.00	0.00	0.67	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	59.01	3.81	4.08	2.18	0.54	0.82	1.36	0.27	0.27	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	47.70	1.61	4.29	1.07	0.00	0.00	0.54	0.00	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	52.00	0.00	0.00	1.79	0.00	0.00	0.00	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	40.79	5.56	8.16	2.78	1.67	0.37	1.67	0.37	0.74	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	33.79	4.98	8.66	1.08	1.08	0.87	0.65	0.87	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	37.62	3.78	7.15	1.47	0.84	1.05	0.84	1.05	0.21	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	71.80	3.03	4.55	1.01	2.02	0.00	0.51	0.00	1.01	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	67.15	5.20	4.33	0.87	1.30	0.00	0.43	0.00	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	62.76	6.54	6.97	1.31	0.87	2.18	1.74	1.31	1.74	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	82.15	4.95	3.96	0.99	2.47	0.49	0.49	0.49	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	72.93	2.77	5.54	0.00	0.00	0.00	0.00	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	65.60	4.19	5.58	1.40	0.00	0.00	0.00	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	73.66	5.26	4.43	2.77	1.38	0.55	1.38	0.55	0.55	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	73.62	4.17	6.38	1.96	0.49	0.49	0.74	1.23	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	80.08	1.54	10.78	1.54	0.00	1.54	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	79.86	7.52	5.01	2.86	0.36	0.72	1.07	0.72	1.07	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	77.56	1.38	6.92	4.15	0.00	1.38	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	54.35	3.27	12.44	2.29	0.33	0.00	0.98	0.65	0.00	1.31
CD8+ T Cells, donor2	11307-117C2	35.29	1.88	6.76	1.13	1.13	1.13	1.50	0.38	0.75	0.75
CD8+ T Cells, donor3	11383-118B6	49.99	2.78	5.30	2.27	0.76	1.01	1.77	0.00	0.50	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	22.02	7.80	6.19	2.29	0.69	0.92	2.29	1.15	0.46	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	28.04	5.75	8.87	2.16	1.44	1.68	0.48	0.96	0.72	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	22.16	6.02	8.75	0.55	1.37	1.64	1.92	1.09	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	19.21	4.80	5.10	2.40	1.80	1.50	2.70	0.30	0.60	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	21.60	6.00	6.96	1.92	1.20	0.96	1.68	0.48	0.48	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	22.97	6.14	6.59	3.87	0.45	0.23	2.05	0.45	0.00	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	22.38	7.60	9.56	4.13	1.09	0.65	0.43	0.87	0.43	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	20.27	5.26	11.32	3.42	1.58	0.79	2.11	1.32	1.32	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	19.00	6.57	9.62	2.35	1.88	0.94	2.35	0.70	1.17	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	21.74	7.25	8.15	1.21	0.60	0.60	2.42	0.91	0.00	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	20.04	5.23	4.07	3.20	1.16	1.45	1.45	0.58	1.16	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	23.98	5.60	4.80	2.66	0.53	1.60	1.07	0.53	1.60	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	23.64	5.25	9.63	5.25	0.88	0.88	0.44	0.44	0.88	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	23.68	4.10	11.39	1.82	0.46	0.46	0.46	0.46	0.46	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	23.87	3.73	4.48	3.73	0.00	0.75	2.24	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	24.85	8.28	10.08	1.80	1.44	1.08	0.72	0.72	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	23.59	6.04	7.48	2.01	0.58	0.86	1.44	2.01	1.15	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	23.57	7.31	6.36	1.65	1.41	1.18	0.94	0.71	0.71	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	32.01	6.34	9.51	3.49	2.22	1.27	1.27	1.27	1.27	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	23.68	6.46	9.23	2.15	1.23	0.31	0.00	0.92	0.62	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	26.29	6.09	8.01	3.53	1.92	0.96	0.64	1.28	0.96	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	24.10	5.74	6.12	1.91	1.91	1.91	0.38	0.38	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.49	5.12	4.73	1.58	0.39	0.39	1.58	0.79	0.79	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	21.94	3.03	7.56	1.51	0.76	1.51	0.00	2.27	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	34.53	9.64	8.03	8.03	0.00	1.61	4.01	0.00	0.00	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	35.67	6.29	5.60	2.10	0.00	2.10	0.00	0.70	0.70	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	51.09	10.02	7.01	6.01	2.00	1.00	1.00	0.00	1.00	2.00
Cardiac Myocyte, donor1	11525-119I4	16.45	7.31	3.66	1.83	1.83	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	9.39	2.96	5.43	0.49	0.00	0.49	0.99	0.00	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	26.73	11.26	6.63	1.58	0.53	0.21	0.42	0.42	0.21	0.53
Chondrocyte - de diff, donor1	11261-116G1	21.15	8.32	9.01	1.39	0.69	0.35	0.69	0.35	0.35	1.39
Chondrocyte - de diff, donor2	11338-117F6	30.92	9.60	6.40	1.78	3.20	0.71	0.71	0.00	0.36	0.71
Chondrocyte - de diff, donor3	11410-118E6	30.38	8.53	7.74	1.48	0.68	1.25	1.37	0.23	0.80	1.02
Chondrocyte - re diff, donor2	11339-117F7	52.82	17.91	12.53	0.00	0.90	0.90	0.90	1.79	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	49.74	10.11	5.66	2.83	1.21	0.81	1.21	0.40	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	36.84	8.03	5.51	2.98	0.80	0.23	0.34	0.69	0.34	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	29.29	7.70	9.41	3.63	1.50	1.07	1.07	1.92	0.86	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	37.26	10.44	9.20	2.65	1.33	0.80	0.80	0.44	0.18	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	93.17	25.68	11.83	2.75	9.08	1.38	1.28	2.38	0.92	0.55
Corneal Epithelial Cells, donor1	11526-119I5	30.08	4.39	4.61	1.98	0.00	0.00	0.66	0.22	0.22	0.44
Corneal Epithelial Cells, donor2	11606-120I4	20.48	4.55	3.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	24.54	2.81	3.07	1.28	0.26	0.00	0.00	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	17.34	5.45	16.51	2.48	0.99	0.00	0.50	0.50	0.00	2.64
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	13.56	5.36	14.19	3.15	1.26	0.00	0.00	0.32	0.00	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	0.00	3.45	6.90	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	16.52	3.46	8.10	2.27	2.59	0.22	0.32	0.22	0.76	1.62
Dendritic Cells - plasmacytoid, donor1	11228-116C4	40.31	1.71	4.10	1.37	0.34	0.68	1.02	1.02	0.68	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	54.19	3.26	2.61	3.26	0.65	0.00	0.00	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	46.46	2.90	2.42	0.48	0.00	0.48	0.00	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	27.35	7.17	11.84	1.33	0.50	0.17	0.00	0.33	0.33	2.50
Endothelial Cells - Aortic, donor1	11263-116G3	20.54	2.93	8.80	3.52	1.17	0.59	0.00	0.59	0.59	2.93
Endothelial Cells - Aortic, donor2	11340-117F8	18.95	6.22	11.59	2.26	0.85	0.57	0.28	0.28	0.28	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	25.95	4.72	11.40	3.15	1.57	0.00	0.00	0.00	0.00	0.79
Endothelial Cells - Artery, donor1	11264-116G4	16.87	5.53	10.76	3.20	1.16	0.29	1.16	0.58	0.00	2.04
Endothelial Cells - Artery, donor2	11341-117F9	27.76	6.12	11.53	3.53	1.65	1.65	1.41	0.71	0.94	1.88
Endothelial Cells - Artery, donor3	11413-118E9	23.14	7.01	9.99	2.45	1.23	0.35	0.35	0.35	1.05	1.40
Endothelial Cells - Lymphatic, donor1	11236-116D3	19.06	3.10	8.64	2.22	0.44	0.22	0.89	0.00	0.00	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	23.43	4.56	6.69	3.04	0.30	0.61	0.00	0.91	0.30	1.22
Endothelial Cells - Lymphatic, donor3	11393-118C7	28.75	8.18	7.61	2.54	0.00	0.56	0.28	0.28	0.85	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	24.66	8.62	8.91	4.46	0.30	0.00	0.59	1.78	0.30	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	20.31	6.77	6.77	0.52	0.52	0.52	0.00	1.04	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	36.44	5.67	9.93	3.83	0.57	0.57	0.99	0.57	0.85	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	20.41	7.20	13.20	0.00	0.80	1.20	0.00	0.00	0.80	1.60
Endothelial Cells - Thoracic, donor2	11343-117G2	23.59	10.48	9.96	3.14	0.52	2.62	1.05	0.00	1.05	4.19
Endothelial Cells - Umbilical vein, donor1	11243-116E1	27.33	5.96	7.83	2.24	0.12	0.25	0.37	0.50	0.50	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	14.56	2.39	5.65	1.30	0.22	0.22	0.00	0.22	0.00	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	21.37	3.91	9.53	2.56	0.00	0.24	0.00	0.00	0.37	0.98
Endothelial Cells - Vein, donor1	11267-116G7	21.61	11.38	6.83	5.69	1.14	0.00	0.00	0.00	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	31.43	15.37	18.86	2.79	1.40	0.70	0.00	0.70	0.70	2.10
Endothelial Cells - Vein, donor3	11416-118F3	31.87	6.91	8.01	2.98	0.94	0.47	0.31	0.16	0.47	0.79
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	186.48	19.80	34.66	6.60	3.30	3.30	0.00	3.30	0.00	0.00
Eosinophils, donor3	12246-129H5	153.37	3.57	57.07	3.57	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	18.57	6.35	3.18	2.20	0.00	0.00	0.24	0.73	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	16.64	2.08	2.08	0.00	0.00	0.00	0.00	0.00	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	32.54	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	22.17	8.21	9.85	4.93	0.82	2.05	0.41	1.23	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.31	4.05	5.91	0.66	0.99	2.08	3.28	1.31	1.31	1.31
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	11.92	5.63	6.61	1.95	0.87	1.30	5.63	1.41	0.54	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	34.08	12.61	12.61	2.79	1.82	0.85	1.21	1.58	0.85	1.70
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	45.31	20.47	23.20	5.60	2.73	0.41	1.23	1.09	0.55	3.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	22.04	8.96	10.44	2.11	1.69	1.37	2.00	0.74	0.95	1.16
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	18.97	13.70	15.02	4.22	1.32	0.79	1.58	0.26	1.32	1.84
Fibroblast - Aortic Adventitial, donor3	11401-118D6	30.23	6.64	13.62	3.32	1.66	1.66	1.00	0.33	1.00	0.66
Fibroblast - Cardiac, donor1	11268-116G8	23.13	13.61	11.79	3.18	0.00	0.45	0.45	0.91	0.00	4.08
Fibroblast - Cardiac, donor2	11345-117G4	47.75	20.46	21.22	6.82	2.27	0.00	0.00	3.03	0.00	2.27
Fibroblast - Cardiac, donor3	11417-118F4	33.91	12.46	12.62	3.15	2.21	1.10	1.10	0.79	1.42	1.42
Fibroblast - Cardiac, donor4	11452-119A3	31.52	7.58	8.79	0.30	0.61	0.00	0.30	0.30	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	25.89	6.47	7.36	1.52	0.76	0.38	0.89	0.89	0.63	0.63
Fibroblast - Cardiac, donor6	11460-119B2	21.98	5.91	7.12	2.12	0.45	1.06	0.91	0.30	0.15	0.91
Fibroblast - Choroid Plexus, donor1	11492-119E7	40.73	14.07	8.17	3.75	2.55	0.27	0.67	0.40	0.13	1.34
Fibroblast - Choroid Plexus, donor2	11572-120E6	14.67	3.02	6.04	0.86	0.00	0.43	0.00	0.43	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	13.18	5.86	2.93	1.46	1.46	0.00	1.46	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	53.51	9.92	6.69	2.54	0.92	0.92	0.46	0.92	0.46	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	31.72	5.26	6.11	2.20	1.19	0.17	0.68	0.17	0.00	0.51
Fibroblast - Dermal, donor1	11269-116G9	16.90	4.46	5.63	2.58	0.94	0.23	0.47	0.23	0.23	0.70
Fibroblast - Dermal, donor2	11346-117G5	21.70	6.13	11.32	2.36	0.94	0.47	0.94	1.42	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	24.18	4.84	4.47	0.85	0.48	0.73	0.73	0.60	0.36	0.36
Fibroblast - Dermal, donor4	11450-119A1	20.35	2.94	4.52	1.47	0.68	1.13	0.34	0.90	0.45	0.34
Fibroblast - Dermal, donor5	11454-119A5	23.20	2.97	5.06	1.57	0.70	0.70	1.40	0.52	0.17	0.17
Fibroblast - Dermal, donor6	11458-119A9	23.55	5.52	5.36	1.46	0.49	0.81	0.97	0.65	0.65	0.32
Fibroblast - Gingival, donor1	11237-116D4	29.15	5.62	6.87	2.71	1.04	0.83	0.62	0.62	0.42	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	26.20	9.69	12.05	1.83	2.62	0.26	1.05	0.52	0.26	0.79
Fibroblast - Gingival, donor2	11318-117D4	27.28	8.04	6.85	3.16	0.79	1.45	1.19	0.92	1.45	0.13
Fibroblast - Gingival, donor3	11394-118C8	29.10	5.32	6.57	2.03	0.87	0.87	0.77	0.19	0.77	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	39.48	11.43	7.27	1.04	2.08	0.00	2.08	1.04	0.00	4.16
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	25.90	7.22	8.28	1.76	0.53	1.06	0.88	0.35	0.53	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	24.16	6.86	12.16	3.74	0.78	0.47	0.94	0.62	0.78	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	24.88	8.93	10.41	3.25	1.62	1.62	1.22	0.95	0.81	1.35
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	34.23	10.23	22.58	6.00	2.47	0.71	0.00	0.00	0.35	1.41
Fibroblast - Gingival, donor7 (control)	11924-125H7	21.21	6.43	9.21	1.75	1.46	0.29	1.17	0.58	0.44	1.75
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	16.77	4.50	12.54	2.18	0.95	1.09	1.23	0.55	0.41	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	18.65	6.58	14.37	3.73	1.32	0.22	0.77	0.44	0.22	1.65
Fibroblast - Gingival, donor9 (control)	11927-125I1	24.80	8.95	7.34	2.05	1.03	0.59	1.32	0.59	0.15	0.44
Fibroblast - Lung, donor1	11270-116H1	28.55	5.44	6.80	5.44	2.72	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	23.87	7.46	7.46	0.00	0.00	0.00	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	39.67	6.33	8.86	1.69	1.90	1.27	1.48	0.63	1.06	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	62.48	19.16	10.83	2.50	5.00	2.50	0.00	0.00	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	23.78	8.39	9.79	2.80	0.00	1.40	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	26.87	9.80	5.04	0.56	1.12	0.56	1.12	0.28	0.00	0.84
Fibroblast - Mammary, donor1	11540-120B1	39.38	16.64	10.96	3.25	2.03	0.00	0.00	0.81	0.00	2.03
Fibroblast - Mammary, donor2	11620-122A9	31.95	19.97	11.98	0.00	0.00	3.99	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	0.00	11.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	31.81	8.34	6.98	2.91	0.78	0.39	1.36	0.78	0.00	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	37.01	8.80	8.19	1.52	0.46	1.82	1.21	1.52	1.37	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	41.00	8.87	14.99	3.37	0.61	0.61	0.61	0.00	0.00	1.53
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	16.03	9.16	13.74	1.14	0.76	1.14	1.14	1.14	0.38	1.53
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	33.21	10.53	8.64	2.16	2.16	1.62	1.35	0.27	0.81	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	27.72	7.54	6.15	2.55	0.58	0.35	0.46	0.35	0.12	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	27.85	9.28	8.29	2.21	0.33	0.66	0.99	0.55	0.55	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	38.00	16.26	16.46	6.10	1.02	0.61	0.20	1.02	0.81	1.42
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	28.73	8.02	6.01	2.00	1.34	2.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	17.00	2.37	4.35	0.79	0.79	0.00	0.40	1.19	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	30.16	22.62	16.67	3.77	4.37	0.99	2.78	0.40	0.99	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	24.51	7.82	6.75	1.07	1.24	0.36	0.18	0.89	0.18	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	28.18	8.08	6.70	2.56	2.17	0.39	0.79	0.79	0.00	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	25.57	10.53	15.34	4.21	2.41	0.90	1.81	0.00	0.90	1.81
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	29.69	9.39	6.15	2.05	2.59	1.08	1.19	0.86	0.97	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	36.19	16.20	13.92	3.54	3.80	1.52	1.27	0.25	1.01	1.77
Fibroblast - skin normal, donor1	11553-120C5	21.66	8.70	7.22	1.15	1.31	0.33	0.16	0.98	0.16	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	39.10	19.85	23.66	7.62	2.61	0.00	1.60	0.60	0.00	2.41
Fibroblast - skin normal, donor2	11561-120D4	38.58	16.17	10.45	3.52	4.42	1.41	2.01	1.61	1.00	1.21
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	31.73	14.51	11.79	3.63	2.42	2.12	1.81	1.51	0.91	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	29.08	7.79	6.21	1.24	1.24	0.33	0.99	0.25	0.25	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	27.86	11.11	7.01	1.37	1.37	0.34	1.71	0.85	0.17	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	25.62	18.39	20.36	3.28	5.25	1.64	2.96	0.66	1.97	1.97
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	49.75	20.24	15.66	5.54	4.15	1.38	2.56	1.28	0.43	2.45
Fibroblast - skin walker warburg, donor1	11554-120C6	29.01	17.37	12.31	2.87	1.86	0.84	0.17	0.67	0.84	1.35
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	21.95	5.80	6.90	2.35	0.78	0.94	8.47	1.41	1.41	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	0.00	44.32	0.00	22.16	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.02	3.49	6.97	1.74	0.87	0.00	0.00	0.00	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	17.51	8.15	8.84	1.91	0.87	0.00	0.35	0.35	0.35	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	23.16	7.55	10.15	3.64	0.26	0.26	0.00	0.00	0.78	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	18.14	5.88	7.67	1.79	0.26	0.51	0.00	0.26	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	21.44	3.83	6.12	0.00	0.00	1.53	0.77	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	12.76	7.66	4.47	4.47	0.00	2.55	1.28	0.00	1.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	31.66	6.28	3.14	4.28	0.00	1.14	1.43	0.00	1.14	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	52.95	6.89	4.96	4.69	0.55	0.55	7.17	1.10	1.10	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	34.48	14.38	5.02	3.42	1.14	0.46	4.79	1.37	1.14	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	25.56	6.54	4.16	5.94	0.40	0.99	3.37	0.59	0.79	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	43.35	7.14	4.76	5.02	0.00	2.38	7.93	2.11	1.06	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	41.09	14.68	8.81	5.22	0.00	1.96	1.96	1.30	0.33	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	19.02	3.98	2.21	2.21	0.00	0.44	3.10	0.44	2.65	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	27.84	7.63	3.39	2.97	1.13	1.55	1.27	0.71	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	38.91	9.73	6.16	4.19	0.49	1.11	3.08	0.74	0.99	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	21.22	6.45	4.57	2.42	0.81	1.07	1.88	0.81	1.34	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	47.95	15.12	6.32	4.46	0.74	0.87	3.72	0.62	0.50	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	40.01	9.41	5.95	4.71	0.97	1.11	2.08	1.25	1.25	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	25.21	6.71	6.71	1.83	0.20	1.22	1.83	1.22	1.02	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	43.13	14.83	9.58	6.16	0.68	1.37	1.83	0.91	0.23	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	42.98	11.83	7.97	5.36	1.00	0.62	2.87	0.25	0.37	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	33.22	7.87	7.21	5.25	0.44	1.53	0.22	0.66	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	48.75	13.00	5.61	2.66	0.59	1.48	2.36	0.30	0.59	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	41.33	11.92	5.40	3.66	0.32	2.38	1.59	0.48	1.43	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	42.45	11.62	4.92	4.47	0.67	0.89	0.45	0.45	0.00	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	49.00	12.30	5.85	3.63	0.81	1.61	2.02	1.01	1.41	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	44.11	16.12	5.94	4.07	0.34	1.70	2.54	1.53	1.02	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	41.50	12.15	8.07	3.64	1.68	0.35	0.80	0.18	0.35	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	81.16	18.31	7.39	5.72	0.73	0.62	0.94	0.21	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	67.12	17.59	7.68	3.24	1.02	0.68	1.20	0.68	0.34	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	41.27	10.84	5.75	3.54	1.33	1.66	2.10	1.00	0.77	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.43	13.98	7.07	3.49	0.92	0.42	1.25	0.58	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	32.87	15.72	6.53	2.45	0.41	0.00	0.61	1.84	0.00	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	61.89	14.44	5.16	3.71	1.44	1.44	2.27	0.83	1.44	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	51.77	7.96	4.61	4.96	0.81	0.92	2.08	0.58	0.69	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	45.53	12.01	8.67	4.00	1.00	1.33	1.83	0.83	0.83	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	43.42	12.78	5.07	2.87	1.10	0.88	1.54	1.10	1.10	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	60.76	11.93	4.80	3.57	0.86	1.84	3.69	1.35	1.35	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	43.12	12.32	9.56	3.73	0.81	0.81	2.43	0.16	0.97	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	57.73	16.36	4.81	3.21	0.96	3.21	1.92	0.96	2.25	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	45.86	13.17	5.59	3.88	1.04	0.66	2.08	0.95	0.47	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	42.55	11.07	6.49	4.43	1.27	1.58	1.74	1.27	0.63	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	47.74	12.77	8.51	2.43	0.91	1.22	1.52	0.30	0.91	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	49.76	14.22	7.63	4.81	1.78	1.57	2.20	0.73	0.94	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	40.18	14.27	7.68	4.17	0.88	1.54	1.10	0.88	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	48.25	19.64	6.73	3.37	1.12	2.24	2.52	1.12	0.84	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	27.87	9.81	9.26	2.69	1.67	0.37	0.83	0.46	0.09	1.11
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	23.80	8.82	6.15	3.74	1.07	0.80	1.34	1.07	0.53	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	28.15	10.10	8.87	4.28	1.84	0.77	0.77	0.77	1.07	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	32.64	11.66	10.88	2.72	2.20	0.39	1.68	0.65	0.65	1.17
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	34.70	14.91	8.95	5.42	1.08	0.81	1.36	0.54	0.81	1.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	29.50	12.35	9.95	3.32	1.29	1.84	0.92	0.37	1.29	1.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	39.91	14.91	6.36	3.73	1.10	1.54	1.75	0.66	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	41.65	18.84	20.83	6.94	1.98	0.99	1.98	1.98	1.98	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	32.98	12.93	9.10	2.77	3.03	1.45	1.71	0.92	0.53	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	33.29	11.30	5.85	3.03	1.82	1.01	1.61	0.81	0.61	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	125.30	45.49	20.08	7.37	3.81	1.52	1.02	1.02	0.76	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	33.44	8.96	3.38	3.98	0.40	0.20	1.19	1.19	0.20	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	28.81	6.16	2.77	2.62	0.31	0.62	1.85	0.15	0.62	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	27.21	5.32	3.48	4.09	0.20	1.23	0.20	0.41	1.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	21.91	8.14	3.76	2.19	0.31	0.31	0.00	0.00	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	15.26	3.96	2.54	2.26	0.57	0.00	0.00	0.00	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	15.22	5.07	4.15	1.38	0.00	0.46	0.46	0.46	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	17.32	4.95	4.95	0.00	0.00	4.95	2.47	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	12.76	7.74	5.42	3.48	0.39	0.39	1.16	0.39	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	6.42	9.63	1.60	1.60	3.21	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	10.43	0.00	1.74	3.48	0.00	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	17.58	9.11	2.60	1.95	0.00	1.95	1.63	0.65	1.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	16.47	6.59	3.29	3.29	0.41	1.24	0.82	1.24	1.65	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	16.66	0.00	6.66	3.33	0.00	6.66	0.00	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	17.06	7.83	1.68	1.96	0.56	1.40	1.40	0.56	1.12	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	17.32	7.52	4.90	2.94	0.65	0.65	1.31	0.98	1.31	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	33.55	5.03	3.36	3.36	0.84	1.68	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	23.54	8.91	5.41	3.18	0.00	0.95	1.91	0.64	0.64	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	24.80	6.79	5.09	3.40	0.34	0.68	0.68	2.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	2.09	4.18	6.26	2.09	0.00	0.00	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	24.05	6.87	5.15	3.44	0.57	2.29	1.15	1.72	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	22.49	5.03	2.66	1.78	0.30	0.59	1.78	1.48	1.18	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	16.94	5.08	1.69	3.39	1.69	0.00	1.69	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	21.95	9.11	5.38	2.90	0.83	4.97	1.66	0.41	1.24	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	22.09	8.74	4.83	2.76	0.46	2.30	1.61	1.15	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	5.27	0.00	10.54	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	15.38	7.69	4.61	1.54	0.38	0.38	1.15	0.38	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	18.58	5.22	4.24	2.61	0.33	0.65	0.33	0.65	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	7.36	5.35	2.01	0.00	0.67	1.34	2.01	0.67	2.01	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	29.28	6.55	2.70	1.54	0.00	3.85	2.70	3.08	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	25.68	6.16	6.50	3.42	0.68	1.37	2.05	1.03	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	39.76	7.45	12.42	2.48	0.00	2.48	0.00	0.00	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	33.50	3.77	2.36	1.42	0.00	2.83	1.89	0.94	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	31.38	4.22	4.22	0.60	0.00	2.41	0.60	3.62	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	35.10	9.66	2.03	2.54	0.51	0.51	0.51	1.02	1.02	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	29.12	6.78	1.99	1.99	0.00	1.99	1.99	1.20	1.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	33.05	8.39	2.96	0.99	0.00	0.99	1.97	0.00	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	33.05	5.90	2.36	1.18	1.18	1.18	4.72	1.18	1.18	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	30.34	7.00	2.33	1.75	0.00	2.33	2.33	0.00	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	38.18	6.14	5.71	3.95	0.00	4.39	1.32	0.44	2.19	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	24.58	3.39	1.70	2.54	0.00	0.85	2.54	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	23.88	3.58	4.18	1.19	0.00	2.39	0.60	1.19	2.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	18.92	7.76	1.46	2.91	0.00	1.46	1.46	1.46	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	23.97	9.13	11.41	0.00	2.28	1.14	0.00	0.00	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	31.60	8.73	6.24	1.25	3.33	0.83	3.74	1.25	0.83	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	49.48	19.12	19.12	2.25	1.12	0.00	0.00	0.00	1.12	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	19.35	7.61	4.44	0.63	1.27	0.32	0.32	0.95	0.63	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	12.11	6.68	5.01	0.84	1.25	0.42	2.09	0.84	1.25	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	17.41	2.90	4.64	2.90	0.46	0.46	0.58	0.58	0.35	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	15.70	3.38	4.90	2.19	0.17	1.18	1.18	1.35	0.34	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	15.24	3.19	3.41	2.28	0.46	0.68	0.68	0.23	0.68	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	21.86	3.28	4.59	2.19	0.22	0.77	1.31	0.44	0.66	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	21.28	3.87	4.94	3.65	0.21	0.43	0.64	0.21	0.21	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	13.78	3.01	5.38	2.37	0.00	0.65	0.43	0.22	0.00	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	19.93	3.61	5.23	3.49	0.25	0.50	1.49	0.50	0.25	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	14.07	2.40	4.63	2.74	0.17	0.17	0.69	0.34	0.34	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	17.62	4.49	3.20	1.28	0.32	0.96	0.96	0.32	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	19.03	1.68	3.36	1.68	0.00	0.56	0.00	0.00	0.56	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	40.68	15.15	7.36	1.73	0.43	1.30	1.73	1.30	0.00	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	2.64	5.29	0.00	0.00	2.64	0.00	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	29.98	8.47	7.05	3.88	1.41	0.35	0.71	0.71	0.00	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	31.24	10.90	7.27	3.63	0.73	2.18	0.00	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	12.76	7.87	4.90	1.22	0.35	0.87	0.70	0.52	0.52	0.52
Hepatocyte, donor1	11523-119I2	14.53	0.00	4.84	1.21	0.00	1.21	2.42	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	10.77	2.15	7.54	0.00	0.00	0.00	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	17.18	2.45	2.45	1.23	0.00	0.61	0.00	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	24.15	1.31	6.53	2.61	0.00	0.00	0.65	0.65	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	36.35	7.87	6.29	1.92	0.35	0.52	1.57	0.35	0.35	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	26.34	10.43	10.70	3.70	1.10	0.00	0.69	1.10	0.14	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	38.21	3.18	9.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	20.03	13.35	6.68	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	30.46	4.15	6.92	5.54	0.00	0.00	0.00	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	25.03	7.51	5.01	2.50	0.00	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	33.32	2.56	20.50	5.13	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	4.57	9.14	4.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	25.99	8.12	12.99	3.25	0.00	0.00	1.62	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	20.01	3.33	3.33	3.33	0.00	1.67	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	0.00	14.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	27.79	1.32	13.23	9.26	0.00	1.32	1.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	23.28	5.54	3.33	4.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	5.24	15.71	15.71	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	30.86	0.63	8.82	6.93	0.00	0.00	0.00	0.00	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	13.92	1.55	15.47	3.09	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	0.00	0.00	0.00	0.00	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	32.95	1.94	10.98	8.40	0.00	0.00	0.00	0.00	0.65	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	28.98	8.05	8.05	8.05	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	35.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	39.93	3.26	8.96	4.89	0.00	0.81	0.00	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	26.45	4.62	7.14	5.88	0.84	0.42	1.26	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	28.93	5.63	17.68	5.63	0.00	0.80	1.61	1.61	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	12.00	1.85	3.69	0.00	0.00	0.00	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	30.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	19.83	1.42	9.44	3.78	0.47	0.47	0.94	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	14.51	1.81	3.63	0.00	0.00	0.91	0.00	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	24.75	2.15	16.14	8.61	0.00	0.00	1.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	13.98	3.81	11.43	10.16	0.00	0.00	1.27	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	16.43	32.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	21.68	3.19	9.57	4.46	0.00	0.64	1.28	0.00	1.28	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	16.40	0.00	12.76	3.65	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	31.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	21.42	2.14	7.85	3.57	0.00	0.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	9.95	16.59	6.64	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	16.98	2.47	8.03	5.25	0.00	0.62	0.31	0.31	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	24.58	5.27	7.02	3.51	0.00	0.00	0.00	1.76	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	3.14	22.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	30.60	1.39	6.95	3.48	0.00	0.70	0.70	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	30.98	2.21	8.85	2.21	0.00	0.00	0.00	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	12.97	0.00	12.97	3.24	3.24	0.00	0.00	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	36.62	1.74	8.72	8.72	0.87	0.00	0.87	0.87	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	24.75	6.75	13.50	9.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	38.33	3.48	10.45	13.94	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	49.07	6.40	9.60	9.60	0.00	1.07	3.20	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	20.78	2.77	11.08	6.93	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	25.65	2.85	8.55	2.85	0.00	2.85	0.00	0.00	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	27.61	1.84	17.49	4.60	0.00	0.92	1.84	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	6.05	24.20	3.03	0.00	0.00	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	12.42	18.63	43.46	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	42.29	2.11	16.92	11.63	0.00	1.06	3.17	1.06	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	22.68	6.69	7.51	2.94	0.65	0.49	0.41	0.82	0.08	1.39
Keratinocyte - epidermal, donor2	11349-117G8	25.77	4.69	3.51	0.00	0.00	0.00	0.59	0.59	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	23.57	3.50	3.22	1.14	0.28	0.38	0.38	0.57	0.57	0.28
Keratinocyte - oral, donor1	11251-116E9	44.73	7.27	4.77	1.14	0.23	0.57	1.02	1.25	0.45	0.23
Keratocytes, donor1	11527-119I6	66.70	11.35	12.03	6.53	0.00	0.00	1.03	1.03	0.00	1.03
Keratocytes, donor2	11607-120I5	23.44	4.69	9.37	2.34	1.17	0.00	0.00	0.00	1.17	1.17
Keratocytes, donor3	11688-122I5	26.87	3.75	4.35	1.19	0.00	0.79	0.00	0.40	0.40	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	17.58	2.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	20.50	12.94	12.94	4.31	2.16	1.08	1.08	0.00	2.16	1.08
Lens Epithelial Cells, donor2	11609-120I7	48.55	11.30	6.80	2.31	0.92	0.35	0.46	0.92	0.23	0.58
Lens Epithelial Cells, donor3	11690-122I7	30.37	12.41	9.49	2.93	0.61	0.10	0.30	0.61	0.30	1.21
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	27.04	5.34	6.05	1.78	0.47	0.95	0.24	0.83	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.91	4.19	2.79	1.40	0.56	0.28	0.56	0.28	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	20.15	5.19	4.72	2.20	0.31	0.63	0.31	0.47	0.31	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	16.13	4.30	4.30	1.08	1.08	0.00	1.08	1.08	0.54	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	14.50	4.41	4.10	0.95	0.32	0.32	0.32	0.63	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	18.87	3.67	4.74	2.70	0.43	0.43	0.54	0.43	0.86	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	16.01	2.46	5.75	0.82	0.41	1.23	0.82	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	20.48	3.29	4.55	1.77	0.25	0.00	0.25	0.25	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	18.58	3.80	4.22	1.41	0.28	0.28	0.14	0.70	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	11.87	5.93	6.33	0.79	1.19	0.40	0.00	0.79	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	18.81	4.07	5.43	1.74	0.19	0.58	0.39	0.58	0.39	1.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	19.44	3.70	3.70	1.48	0.37	0.56	0.37	0.93	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	18.12	5.57	6.27	0.35	0.35	0.70	0.35	0.35	0.70	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	18.13	4.29	5.49	2.39	0.00	0.48	0.00	0.48	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	17.72	3.02	3.85	1.92	0.27	1.10	0.55	0.41	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	17.55	4.93	5.24	0.92	0.31	0.31	0.62	0.62	0.00	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	20.26	3.74	4.68	1.56	0.31	0.62	0.62	0.62	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	21.41	4.94	6.40	0.73	0.37	1.10	0.73	0.37	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	21.06	3.95	1.97	2.30	0.66	0.00	0.33	0.33	0.99	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	15.82	4.10	4.98	1.17	0.29	0.59	0.59	0.88	1.17	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	16.18	6.22	4.23	2.49	0.75	0.75	0.25	0.25	0.25	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	16.97	3.88	3.88	0.48	0.48	0.48	0.00	0.97	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	18.85	4.04	3.23	0.54	0.54	0.27	0.27	0.81	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	15.29	2.88	2.57	1.36	0.61	0.91	0.61	0.30	0.76	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	13.48	6.22	6.22	2.07	0.00	0.52	0.00	0.52	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	20.10	4.19	4.82	2.51	0.42	0.21	0.84	0.00	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	18.35	3.91	3.61	1.05	0.60	0.30	0.30	0.60	0.90	1.35
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	19.95	2.75	6.19	1.38	0.00	2.75	0.00	0.00	1.38	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	17.50	3.76	3.20	2.45	0.19	0.19	0.38	0.75	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	21.95	4.03	4.03	1.70	0.85	1.06	0.53	0.53	0.85	0.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	18.41	8.24	8.24	1.94	0.00	0.48	0.97	0.97	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	22.16	4.96	4.96	1.32	0.99	0.00	0.33	0.33	0.33	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	21.06	4.83	4.83	0.99	0.74	1.12	0.50	0.25	0.25	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	14.44	4.81	5.92	1.48	0.00	0.37	0.00	0.37	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	12.11	3.21	5.19	1.24	0.49	0.25	0.25	0.99	0.74	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	16.77	4.67	4.81	1.24	0.41	1.10	0.69	0.00	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	20.91	4.18	6.11	2.25	0.00	0.64	0.64	0.32	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	17.65	4.87	3.65	0.00	0.91	0.30	0.61	0.30	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	17.36	4.06	4.62	1.26	0.14	0.28	0.14	0.56	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	22.76	6.76	6.40	2.13	0.71	0.00	0.36	1.07	0.36	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	19.88	4.36	2.91	1.94	1.45	0.00	0.97	0.97	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	21.63	4.98	5.76	1.09	0.16	1.24	0.78	0.78	0.31	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	18.98	6.09	8.59	1.07	0.36	0.00	0.36	1.07	0.36	2.15
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	18.29	5.55	3.27	1.63	1.63	0.65	0.00	0.00	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	19.30	3.53	4.94	0.71	0.71	0.71	0.24	0.47	0.47	0.94
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	30.07	8.54	8.04	2.72	0.74	0.62	0.99	0.87	0.62	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	24.59	8.20	4.35	3.07	0.51	1.02	0.26	0.77	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	21.78	3.28	4.18	2.09	0.00	1.19	0.90	0.00	0.30	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	74.78	9.06	15.86	9.06	0.00	6.80	0.00	0.00	4.53	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	55.23	8.44	16.88	5.37	0.77	1.53	2.30	1.53	2.30	3.07
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	29.69	8.91	13.36	5.94	1.48	0.74	2.23	1.48	1.48	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	43.16	11.42	17.77	6.77	0.85	2.54	2.96	0.85	1.27	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	35.87	16.18	19.69	9.85	0.70	0.00	0.70	0.70	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	29.89	5.60	8.41	5.60	1.87	0.00	1.87	0.00	1.87	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	29.37	11.85	14.43	3.61	1.03	1.55	7.21	2.58	5.15	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	36.87	10.71	16.65	11.89	0.00	2.38	4.76	1.19	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	52.70	9.73	16.29	10.63	0.90	1.36	1.81	3.62	0.23	1.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	32.28	7.27	17.45	4.36	0.58	3.20	3.49	1.74	2.04	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	27.01	9.90	13.06	2.25	1.35	4.95	2.25	0.45	1.80	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	68.01	13.96	24.39	8.81	0.95	1.49	1.63	0.95	0.54	1.90
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	39.54	10.78	13.35	8.22	2.05	2.57	5.65	1.03	3.08	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	32.11	4.94	13.06	6.70	1.41	0.71	3.18	0.71	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	21.32	9.33	11.33	3.33	1.33	1.33	2.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	37.19	8.66	15.28	8.66	1.02	2.04	2.04	1.02	2.55	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	35.49	8.80	14.94	5.34	1.07	4.27	1.87	1.60	1.60	1.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	37.22	7.37	16.44	4.72	0.76	2.08	2.65	1.13	1.13	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	41.72	15.34	16.57	9.20	0.00	1.84	4.91	3.07	1.23	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	53.82	6.52	14.68	7.34	1.63	4.08	4.08	1.63	1.63	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	34.98	8.95	15.41	4.58	1.67	3.12	6.04	1.67	1.25	1.87
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	25.50	7.01	12.61	5.04	1.12	3.36	6.17	2.52	1.40	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	42.24	10.30	22.67	7.21	1.03	1.03	5.15	1.03	1.03	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	32.51	7.84	15.97	6.10	1.16	2.61	2.90	2.90	3.77	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	25.71	8.07	13.75	6.58	0.60	3.29	1.79	1.49	1.79	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	29.32	9.41	15.49	6.64	2.77	2.77	2.21	0.00	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	46.31	12.02	22.62	9.90	1.06	2.47	5.30	3.18	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	42.04	10.69	15.12	5.16	0.37	3.32	3.69	2.58	1.84	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	35.69	14.97	17.27	4.61	1.15	0.00	3.45	0.00	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	45.67	10.75	23.79	4.99	0.77	3.07	0.77	1.92	3.07	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	32.84	11.89	19.25	5.66	0.00	5.10	5.10	2.83	2.26	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	41.84	10.67	18.87	9.03	0.82	4.10	3.28	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	40.22	12.65	25.31	6.33	0.90	3.62	3.16	3.62	3.16	3.16
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	36.63	8.62	12.93	4.31	2.87	1.44	3.59	2.87	1.44	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	35.10	9.71	14.19	8.22	2.99	2.24	2.99	0.00	1.49	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	54.62	9.66	18.58	7.43	2.23	9.29	11.15	0.74	2.97	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	37.48	10.77	18.09	4.74	1.72	2.58	0.86	1.29	2.58	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	36.82	11.13	21.41	15.41	0.00	5.99	2.57	0.00	0.00	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	46.64	14.33	20.32	5.33	1.00	5.00	5.33	3.66	2.33	2.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	46.45	11.46	23.53	11.46	1.81	3.62	1.81	1.81	0.60	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	46.21	9.24	14.93	7.11	2.13	1.42	0.71	0.71	2.84	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	46.40	19.25	16.84	6.87	1.72	3.78	2.06	1.03	2.75	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	32.74	13.96	25.76	4.83	1.07	4.29	3.22	0.00	4.83	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	28.95	19.53	16.16	7.41	0.67	1.35	4.04	1.35	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	45.93	11.11	27.41	4.44	1.11	3.70	4.82	1.48	4.07	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	46.52	12.79	19.77	6.98	0.00	1.16	0.00	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	41.25	12.69	15.87	11.64	2.12	0.00	0.00	3.17	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	52.82	14.81	19.21	8.40	2.40	2.80	3.20	2.40	2.00	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	39.25	8.00	17.44	5.09	0.00	3.63	2.18	2.91	1.45	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	55.19	15.33	22.23	9.20	2.30	0.77	3.07	1.53	2.30	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	44.39	14.31	20.22	6.91	0.99	2.96	3.95	4.93	3.45	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	33.87	11.29	14.11	4.70	1.88	0.94	1.88	3.76	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	39.72	11.56	15.08	6.54	2.51	2.01	2.01	2.51	1.51	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	38.30	12.17	20.73	4.96	0.90	4.06	0.90	3.15	3.15	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	24.10	8.61	22.37	3.44	0.00	1.72	5.16	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	49.43	12.47	18.70	8.46	3.56	1.34	4.01	2.67	2.23	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	46.53	16.03	21.12	6.26	0.00	4.30	1.96	1.56	3.13	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	34.97	5.28	22.43	7.26	0.66	3.30	2.64	1.98	1.32	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	44.11	10.90	22.31	6.75	1.04	2.59	0.52	1.56	1.04	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	36.76	12.69	18.82	7.00	0.00	3.94	2.19	1.75	3.06	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	35.78	11.18	15.65	6.71	0.00	1.12	1.12	2.80	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	42.84	12.81	15.02	3.97	1.32	3.97	1.32	2.21	0.44	3.09
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	52.84	12.34	20.06	7.71	0.77	2.70	1.93	0.77	1.54	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	31.39	7.09	17.22	3.54	0.00	1.01	2.53	2.53	2.03	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	38.93	11.05	20.67	6.73	0.48	0.96	1.92	0.96	0.48	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	35.38	13.91	22.26	5.96	0.80	2.39	1.99	1.99	3.98	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	30.38	6.68	17.01	6.68	1.22	1.22	1.82	4.25	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	28.36	8.99	12.45	4.84	2.77	2.08	3.46	2.77	2.08	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	47.12	13.68	19.00	6.08	0.00	3.42	4.56	1.14	3.42	2.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	41.83	12.91	16.01	8.26	1.55	4.65	4.13	1.03	2.07	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	26.60	12.70	15.12	5.44	1.21	0.60	4.84	1.21	1.21	3.63
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	39.93	13.31	14.89	8.24	0.32	4.44	2.85	2.22	1.58	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	41.58	17.59	25.59	6.40	3.73	2.67	3.20	2.13	1.07	3.73
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	32.18	13.22	17.24	5.17	1.72	0.57	0.00	1.72	1.15	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	53.99	11.83	24.17	5.14	1.03	6.69	9.26	2.06	0.51	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	48.81	13.44	19.81	8.49	1.41	2.12	2.83	2.83	2.83	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	28.94	11.92	15.32	7.94	2.27	1.70	3.40	1.13	3.40	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	47.43	19.55	20.39	5.41	2.08	4.58	5.41	3.74	2.91	3.33
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	46.20	14.88	21.93	4.70	3.13	4.70	1.57	3.13	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	32.57	19.62	18.37	4.18	1.25	2.92	2.51	2.92	1.67	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	46.46	24.16	24.16	5.11	0.46	3.25	1.86	0.93	2.79	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	42.82	17.40	26.09	7.36	0.00	3.35	2.68	0.00	2.01	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	39.56	21.39	15.50	3.21	2.67	1.60	4.81	2.14	1.60	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	61.42	18.99	25.05	10.10	1.62	8.89	4.04	2.42	3.23	4.45
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	42.22	22.03	22.03	3.67	2.75	3.67	3.67	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	40.90	24.01	17.78	5.33	2.67	2.67	2.67	0.89	1.78	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	65.53	22.22	25.07	7.98	2.85	3.42	5.13	1.14	0.57	4.56
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	44.48	13.04	26.84	13.80	0.77	1.53	3.07	1.53	3.07	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	38.30	20.25	22.98	9.30	2.74	2.19	2.74	3.28	2.19	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	61.47	17.82	29.40	7.13	4.01	7.57	3.12	2.23	2.23	3.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	77.73	32.75	30.67	17.42	3.12	0.78	1.30	4.68	0.78	4.16
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	50.40	22.55	19.23	7.96	2.65	3.98	4.64	3.32	2.65	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	56.12	18.71	43.65	4.16	2.08	14.55	10.39	4.16	2.08	4.16
Macrophage - monocyte derived, donor1	11232-116C8	14.13	2.28	7.52	2.28	2.28	0.68	0.00	0.00	0.00	0.46
Macrophage - monocyte derived, donor2	11313-117C8	17.98	7.52	11.19	5.69	0.92	0.37	0.00	0.37	0.18	1.47
Macrophage - monocyte derived, donor3	11389-118C3	19.53	4.06	12.06	2.88	1.57	0.39	0.39	0.26	0.26	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	7.43	5.31	3.19	2.12	0.53	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	18.06	9.51	8.71	2.06	0.48	1.27	1.27	0.48	0.16	1.90
Mallassez-derived cells, donor3	11930-125I4	20.85	8.20	7.51	2.78	0.00	0.14	1.67	0.97	0.14	0.69
Mammary Epithelial Cell, donor1	11273-116H4	30.39	5.68	6.18	1.59	0.20	0.40	0.40	0.80	0.40	0.30
Mammary Epithelial Cell, donor2	11350-117G9	28.38	5.21	7.82	1.45	0.00	0.29	0.87	1.45	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	29.68	4.99	7.23	2.99	0.00	0.75	0.00	0.25	0.50	0.50
Mast cell - stimulated, donor1	11487-119E2	71.18	16.95	8.14	0.00	2.03	2.03	2.03	1.36	0.00	0.00
Mast cell, donor1	11563-120D6	39.26	5.95	6.27	1.51	1.41	0.22	1.30	0.54	0.00	0.54
Mast cell, donor2	11565-120D8	65.97	3.27	3.86	0.00	0.30	0.30	0.59	1.19	0.00	0.00
Mast cell, donor3	11566-120D9	71.36	2.48	4.95	0.90	0.45	1.13	1.58	1.35	0.00	0.00
Mast cell, donor4	11567-120E1	54.78	2.84	3.01	1.42	0.89	0.89	0.71	1.06	0.18	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	35.71	3.22	5.10	1.55	0.89	0.78	2.11	0.44	0.00	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	18.68	5.25	7.59	5.84	2.33	1.17	1.75	1.17	0.00	1.17
Mast cell, expanded, donor5	11939-126A4	47.27	5.74	6.77	2.29	0.92	0.57	1.84	1.15	0.57	0.46
Mast cell, expanded, donor8	11941-126A6	31.13	4.52	12.55	2.51	1.34	0.33	2.01	0.84	0.33	0.50
Melanocyte - dark, donor1	11502-119F8	17.61	3.78	3.98	1.49	0.40	0.10	0.00	0.10	0.10	0.40
Melanocyte - dark, donor2	11582-120F7	8.65	2.77	4.15	2.42	0.35	0.35	0.35	0.35	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	54.69	18.76	15.94	5.51	1.96	0.58	0.80	1.67	0.51	1.23
Melanocyte - light, donor1	11274-116H5	51.95	9.64	15.28	5.41	2.12	0.47	0.24	1.18	0.24	1.18
Melanocyte - light, donor2	11351-117H1	43.68	9.55	15.70	3.41	1.36	2.73	0.00	1.36	0.68	0.00
Melanocyte - light, donor3	11423-118G1	29.49	6.94	19.08	2.60	1.73	0.87	1.73	0.87	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	45.19	8.75	7.81	3.33	1.04	1.46	2.29	0.83	1.35	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	28.51	12.64	13.18	2.96	3.77	0.54	2.42	0.81	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	38.30	5.62	12.05	2.14	1.34	2.41	1.61	1.07	0.80	1.34
Meningeal Cells, donor1	11493-119E8	49.87	14.76	10.30	3.72	1.49	0.37	0.37	1.36	0.62	1.61
Meningeal Cells, donor2	11573-120E7	41.81	13.20	6.16	3.08	1.76	0.88	0.00	0.44	0.44	0.44
Meningeal Cells, donor3	11654-122E7	29.34	10.51	10.84	2.20	1.63	0.65	0.65	1.06	0.41	0.65
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	33.93	7.13	6.56	2.57	0.86	0.29	0.29	2.00	0.00	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	19.52	9.86	13.28	4.13	2.01	0.10	0.50	0.50	0.30	2.01
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	22.34	3.94	6.57	1.31	1.31	1.31	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	20.93	9.16	5.23	1.31	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	21.53	3.59	7.89	2.87	1.44	2.15	0.72	0.72	0.00	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	26.05	8.47	7.84	2.54	1.06	1.27	1.06	0.64	0.42	1.48
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	17.59	10.56	13.07	4.02	1.01	2.01	1.51	1.01	0.50	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	31.42	13.40	10.11	3.74	1.54	0.44	0.00	1.54	0.22	2.20
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	40.18	18.26	16.80	4.38	2.19	2.19	1.46	0.73	0.00	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	42.35	17.19	18.21	5.73	1.64	1.64	0.41	0.61	0.61	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	41.55	9.97	4.02	0.55	1.25	0.28	0.42	1.11	0.00	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	29.74	10.78	4.83	2.23	0.37	0.74	0.74	1.49	1.49	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	37.50	9.87	5.00	2.76	1.05	0.92	1.32	1.18	0.26	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	28.49	6.83	4.45	2.67	0.89	0.30	1.48	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	25.69	0.00	7.01	0.00	0.00	4.67	0.00	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	21.77	8.97	5.76	3.84	0.00	0.00	0.00	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	34.38	10.28	11.34	2.84	0.35	1.06	0.35	0.71	0.71	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	40.65	6.88	4.69	0.94	0.94	0.00	1.25	1.25	0.00	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.05	5.81	5.81	2.18	0.73	0.00	0.00	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	23.60	7.42	7.69	2.39	0.27	1.33	0.27	0.00	0.27	0.80
Mesothelial Cells, donor2	12156-128G5	16.52	8.51	10.51	5.00	2.00	0.00	0.00	0.00	0.00	1.00
Mesothelial Cells, donor3	11402-118D7	20.81	7.66	6.58	1.66	0.51	0.58	0.87	0.58	0.22	0.94
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	9.45	2.70	37.81	5.40	1.35	0.00	0.00	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	10.34	4.93	9.85	3.45	0.74	0.00	0.00	0.25	0.25	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	13.55	4.71	12.07	4.71	1.47	0.29	0.29	0.00	0.00	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	3.46	55.31	3.46	0.00	0.00	0.00	0.00	0.00	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	10.23	2.17	6.51	2.48	0.31	0.31	0.00	0.31	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	13.48	4.56	9.13	2.90	0.41	0.21	0.00	0.21	0.00	2.90
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	0.00	27.79	4.63	0.00	0.00	0.00	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	13.26	4.00	10.01	5.51	0.50	0.00	0.50	0.00	0.25	1.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	9.31	3.26	10.71	1.86	1.40	0.00	0.00	1.40	0.00	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	38.93	0.00	0.00	0.00	0.00	0.00	0.00	38.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	10.77	3.45	9.14	3.25	0.81	0.81	0.20	0.20	0.61	1.22
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	11.88	3.17	11.48	3.56	0.79	0.40	0.79	0.40	0.40	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	42.76	8.55	0.00	0.00	0.00	0.00	0.00	8.55
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	9.73	0.88	6.19	0.00	0.88	0.00	1.77	0.88	0.00	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	7.60	4.56	12.54	3.04	2.28	0.00	0.38	0.38	0.00	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	1.32	15.79	0.00	0.00	0.00	0.00	0.00	0.00	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	10.82	1.70	6.37	2.55	0.42	0.64	0.00	0.64	0.00	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	6.45	2.76	15.65	0.92	0.00	0.00	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	8.94	1.79	9.54	3.87	0.60	0.00	0.89	0.00	0.00	2.98
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	1.68	50.30	1.68	0.00	0.00	0.00	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	33.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	11.54	2.51	7.28	3.76	0.50	0.00	1.00	0.25	0.00	1.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	8.32	4.04	13.31	2.85	1.43	0.48	0.24	0.24	0.00	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	13.27	2.76	15.48	5.53	0.00	0.00	0.00	0.00	0.00	2.76
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.74	3.45	9.90	2.99	0.46	0.23	0.23	0.23	0.00	1.38
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	15.35	4.63	9.68	2.94	1.05	0.00	0.00	0.42	0.00	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	10.80	2.65	9.38	3.87	0.20	0.41	0.41	0.00	0.00	1.83
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	9.01	2.57	8.15	3.86	0.64	0.00	0.86	0.21	0.00	1.93
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	10.89	5.11	10.67	3.11	0.67	0.22	0.00	0.22	0.00	1.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	51.59	10.32	0.00	0.00	0.00	0.00	0.00	20.64
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	12.05	1.10	7.67	1.97	0.44	0.00	0.00	0.88	0.44	1.97
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	15.72	4.06	14.70	3.55	1.01	0.00	0.00	0.00	0.00	3.04
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	14.91	4.97	18.23	3.31	0.00	0.00	0.00	0.00	0.00	4.97
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	15.76	2.99	13.32	4.62	0.54	0.54	0.00	0.27	0.27	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	11.76	3.53	12.94	3.53	0.59	0.00	0.29	0.29	0.00	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	0.00	17.45	5.45	0.00	0.00	0.00	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	9.61	2.40	4.81	4.81	0.48	0.48	0.48	0.00	0.00	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	7.20	5.60	14.41	4.00	0.40	0.00	0.00	0.00	1.20	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	1.37	24.68	8.23	0.00	0.00	0.00	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	14.02	3.50	9.01	3.00	0.50	1.00	0.50	0.00	0.50	2.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	53.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	2.04	28.54	10.19	0.00	0.00	0.00	0.00	0.00	4.08
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	9.63	2.19	10.51	4.82	0.88	0.00	0.00	0.44	0.88	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	13.24	4.41	30.90	12.14	1.10	0.00	0.00	0.00	0.00	9.93
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.89	1.28	23.05	3.20	0.64	0.00	0.00	0.00	0.64	2.56
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	10.41	2.98	10.16	3.97	0.50	0.50	0.74	0.25	0.50	1.49
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	11.13	2.78	18.79	5.57	0.00	0.70	0.00	0.00	0.00	5.57
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	8.84	39.78	6.63	0.00	0.00	0.00	0.00	0.00	8.84
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.28	4.44	9.57	3.76	0.68	0.34	0.68	0.68	0.00	2.05
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	5.69	3.50	17.94	8.75	0.88	0.00	0.00	0.00	0.00	3.50
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	14.56	2.13	23.44	6.39	0.00	0.00	0.00	0.00	0.00	2.84
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	13.75	3.09	9.82	4.21	0.28	1.12	0.56	0.28	0.84	1.96
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	13.72	5.40	15.79	7.07	0.83	0.00	0.00	0.00	0.00	3.33
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	13.40	2.91	17.48	5.83	0.00	0.00	0.00	0.00	0.58	5.83
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.76	4.22	9.95	5.43	0.30	0.90	0.60	0.60	0.30	2.11
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	10.85	7.93	9.18	5.01	0.00	0.00	0.00	0.42	0.00	2.50
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	14.44	28.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	15.70	0.00	13.85	2.77	0.92	0.92	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	11.38	7.40	13.09	4.55	1.14	0.57	0.00	0.57	0.00	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	15.06	3.45	13.68	5.53	0.41	0.28	0.41	0.00	0.14	1.24
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	15.55	4.92	10.63	2.59	1.30	0.52	0.78	1.04	0.52	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	10.30	5.58	14.59	4.72	0.00	0.43	0.00	0.00	0.43	3.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	13.34	3.18	26.04	6.35	0.00	0.00	0.00	0.00	0.00	3.81
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	12.54	3.47	13.61	4.27	0.00	0.00	0.00	0.00	0.27	1.60
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	13.47	8.38	12.57	3.89	0.30	0.00	0.00	0.30	0.30	2.99
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.44	2.12	8.62	4.24	0.14	0.14	0.28	0.14	0.42	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	10.19	3.82	8.60	4.78	1.59	1.27	1.27	0.64	0.00	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	13.71	5.53	9.51	3.10	0.66	0.44	0.00	0.44	0.00	2.21
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.51	2.65	12.51	7.20	0.38	0.00	0.00	0.00	0.00	1.52
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	11.65	4.26	8.24	4.83	0.28	0.28	0.00	0.00	0.00	1.42
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	14.26	2.46	9.83	3.69	1.23	0.25	0.25	0.74	0.74	2.21
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	16.94	3.91	17.60	6.52	0.00	0.00	0.00	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.88	2.35	10.00	3.23	0.59	0.29	0.59	0.00	0.00	1.76
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	16.15	5.19	13.55	5.19	1.44	0.58	0.86	0.58	0.00	2.31
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	22.26	5.36	11.13	3.71	0.82	0.00	0.41	0.00	0.00	2.06
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	12.51	5.66	7.74	2.68	0.89	0.60	0.00	0.30	0.00	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	3.77	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	0.00	7.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	11.83	1.31	9.20	2.63	0.66	0.33	0.66	0.33	0.99	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	12.62	2.10	8.42	4.21	0.00	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	7.12	2.57	9.09	2.97	0.59	0.00	0.00	0.20	0.20	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	12.11	1.86	16.76	3.73	0.00	0.00	0.00	0.00	0.00	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	11.64	2.63	7.89	3.00	0.00	1.13	0.38	0.38	0.38	2.25
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	9.59	3.20	9.59	2.13	1.07	0.00	0.27	0.27	0.27	2.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	7.69	2.94	8.14	2.15	0.34	0.23	0.00	0.23	0.00	0.45
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	12.52	2.21	10.31	0.74	0.00	0.00	0.74	0.74	1.47	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	9.89	2.56	5.50	4.76	0.37	0.37	1.10	0.37	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	14.00	0.00	12.44	1.56	1.56	3.11	1.56	3.11	0.00	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	12.83	6.41	12.83	2.67	2.14	0.00	0.00	0.53	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	3.86	0.00	0.00	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	9.09	2.02	4.04	2.02	0.00	1.01	0.00	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.85	5.48	11.81	3.79	1.26	0.00	0.00	0.42	0.00	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	16.34	8.17	8.17	4.09	1.36	0.00	2.72	1.36	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	14.62	6.99	8.90	2.54	1.27	0.00	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	10.53	4.05	4.86	1.62	0.81	0.00	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	6.04	10.57	1.51	0.00	0.00	1.51	0.00	0.00	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	5.71	0.00	5.71	0.00	0.00	0.00	0.00	0.00	11.42
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	35.89	13.05	6.52	3.26	0.00	0.00	0.00	0.00	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	14.26	4.75	4.75	0.00	0.00	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	37.65	37.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	30.59	14.22	17.02	2.37	1.72	0.86	1.94	0.86	0.86	2.15
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	20.38	7.84	8.88	2.09	0.00	0.52	0.00	0.00	2.09	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	5.34	3.34	10.01	0.67	1.33	0.00	0.67	0.67	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	7.93	2.92	12.10	0.83	0.83	0.42	0.00	0.00	0.42	1.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	16.16	9.70	6.08	1.33	0.76	0.57	3.99	0.38	0.57	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	31.92	9.58	12.77	4.79	1.60	0.00	0.00	0.00	1.60	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	7.48	1.36	4.76	1.36	0.68	0.00	0.68	0.68	0.68	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	27.56	7.35	7.35	5.51	1.84	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.86	1.26	7.95	0.84	0.00	2.09	0.00	0.00	1.26	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	8.37	2.32	8.37	1.86	0.46	0.46	1.16	0.00	0.23	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	4.05	1.62	5.67	0.81	0.27	0.27	0.27	0.00	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	10.72	3.99	7.57	1.68	0.42	0.21	0.21	0.21	0.00	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	0.00	11.13	11.13	0.00	11.13	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.94	1.49	8.44	0.00	0.00	0.99	2.48	0.00	0.99	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	6.77	3.79	1.35	0.81	0.00	0.54	1.62	0.00	0.54	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	4.08	1.36	7.03	0.91	0.23	0.00	1.13	0.91	0.23	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	4.57	1.96	6.04	1.14	0.00	0.65	0.49	0.00	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	10.94	3.10	3.28	1.46	0.55	1.09	0.55	0.18	0.55	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	6.90	0.00	3.18	1.06	0.00	0.00	1.06	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	5.40	1.20	6.60	0.00	0.00	1.20	2.40	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	10.50	3.28	1.64	0.66	0.66	0.33	5.25	0.00	0.66	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	2.93	1.63	5.04	0.65	0.33	0.49	0.81	0.33	0.33	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	12.70	3.17	5.64	2.12	0.88	0.35	0.35	0.18	0.53	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	2.81	1.41	3.52	0.00	0.00	0.00	0.00	1.41	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	3.68	1.38	4.60	0.00	0.00	0.92	1.38	0.00	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	5.78	1.29	5.78	0.32	0.32	0.00	0.96	0.32	0.64	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	17.59	4.14	3.79	0.00	0.00	0.34	12.76	0.69	2.07	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	37.93	7.59	2.53	2.53	2.53	0.00	0.00	0.00	7.59	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	12.03	3.34	6.91	2.23	0.89	0.00	0.00	0.22	0.00	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	4.23	2.12	3.81	1.27	0.42	0.00	0.85	0.00	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	5.70	1.19	3.09	1.19	0.47	0.24	0.95	0.24	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	5.15	0.86	7.30	0.43	0.43	0.00	1.29	0.00	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	9.03	18.06	0.00	0.00	9.03	0.00	0.00	18.06	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	7.00	1.00	3.33	1.00	0.67	0.67	0.67	0.00	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	10.82	1.80	10.37	2.71	0.45	0.00	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	4.76	0.79	5.95	0.40	0.40	0.79	0.40	1.59	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	3.71	0.93	6.50	0.93	1.86	0.00	0.00	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	10.97	1.89	3.03	0.76	0.00	0.38	0.76	0.00	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.54	1.63	6.84	1.63	0.65	0.65	1.30	0.00	0.00	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	9.15	0.87	2.18	1.31	0.00	0.00	0.44	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	13.12	4.98	4.07	0.00	0.45	0.00	0.00	0.45	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	4.41	1.76	0.88	0.88	0.00	0.00	4.41	0.88	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5.32	1.33	3.99	0.66	0.00	1.33	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	8.43	0.99	3.47	0.50	0.50	0.50	0.99	0.50	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.13	1.91	4.98	1.15	0.00	0.00	0.77	0.00	0.38	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	17.84	3.63	5.75	0.91	1.21	0.91	1.51	0.91	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	11.49	4.20	5.30	1.11	0.44	0.22	0.44	0.00	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.74	0.68	6.10	0.68	0.00	1.36	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	10.22	0.00	5.11	0.00	0.00	0.00	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	3.66	0.00	1.83	0.61	0.00	0.00	0.00	1.22	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	7.55	2.83	5.98	1.26	0.00	0.00	0.31	0.00	0.00	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	5.75	2.12	3.93	0.91	0.00	0.00	1.21	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	5.54	2.37	3.16	1.58	1.58	3.16	0.79	0.00	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	14.74	2.27	2.27	2.27	0.00	0.00	9.07	0.00	3.40	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	0.00	0.00	0.00	0.00	0.00	10.12	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	24.10	10.31	12.67	2.61	1.99	0.75	0.75	0.75	0.25	2.48
Myoblast, donor2	11322-117D8	18.60	7.10	16.88	0.00	1.34	0.96	0.77	0.58	1.15	2.88
Myoblast, donor3	11398-118D3	29.93	8.41	10.26	3.87	1.85	0.50	0.34	0.67	0.17	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	41.01	4.52	6.13	2.33	0.15	0.58	0.58	0.73	0.73	0.73
Natural Killer Cells, donor1	11230-116C6	39.36	2.46	9.84	2.15	0.62	0.00	0.92	0.92	0.00	0.31
Natural Killer Cells, donor2	11311-117C6	37.69	1.51	6.03	0.60	0.90	1.81	1.51	0.60	1.51	0.90
Natural Killer Cells, donor3	11387-118C1	40.68	2.58	7.73	1.66	0.74	0.74	1.29	0.55	0.55	0.00
Neural stem cells, donor1	11275-116H6	156.79	71.50	45.00	15.61	8.71	2.90	3.27	1.45	1.81	4.36
Neural stem cells, donor2	11352-117H2	313.88	159.83	32.74	23.11	13.48	5.78	1.93	3.85	3.85	1.93
Neurons, donor1	11494-119E9	100.14	63.72	19.34	11.38	11.38	5.69	7.97	7.97	2.28	1.14
Neurons, donor2	11574-120E8	248.12	134.08	25.54	12.33	9.47	3.08	7.27	6.60	2.42	1.10
Neurons, donor3	11655-122E8	59.20	42.75	23.84	13.15	5.76	13.98	15.62	6.58	10.69	2.47
Neutrophils, donor1	11233-116C9	47.33	1.86	15.78	3.71	0.00	0.93	6.50	0.93	0.93	0.00
Neutrophils, donor2	11314-117C9	28.99	2.90	2.90	2.90	0.00	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	78.19	1.83	21.99	6.11	0.61	2.44	1.22	1.22	0.00	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	39.18	7.24	4.16	1.07	0.36	0.36	0.83	0.36	0.12	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	18.23	3.58	3.58	0.98	0.65	0.98	1.30	0.33	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	21.46	5.41	3.41	1.00	1.00	1.20	1.00	0.80	0.40	0.20
Olfactory epithelial cells, donor1	11933-125I7	12.94	2.89	9.36	1.79	0.96	0.96	0.69	0.14	0.69	0.55
Olfactory epithelial cells, donor2	11934-125I8	15.63	5.65	12.59	1.45	1.30	2.61	3.62	1.59	2.17	1.01
Olfactory epithelial cells, donor3	11935-125I9	13.28	3.41	9.08	1.70	1.02	1.25	0.91	0.79	1.14	0.45
Olfactory epithelial cells, donor4	11936-126A1	21.33	6.53	9.93	2.73	0.58	0.68	0.39	0.58	0.68	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	37.91	12.04	6.62	3.61	1.20	0.60	0.00	1.20	0.60	1.20
Osteoblast - differentiated, donor1	11276-116H7	40.41	9.36	9.78	2.77	1.28	0.43	0.21	0.21	0.43	0.64
Osteoblast - differentiated, donor2	11353-117H3	18.29	2.29	11.43	3.43	0.00	4.57	0.00	2.29	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	24.83	5.59	8.69	2.48	0.00	0.00	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	43.19	11.73	15.05	5.28	1.37	0.39	0.00	0.78	0.00	0.59
Osteoblast, donor2	11354-117H4	29.50	14.05	11.24	2.11	1.40	0.70	3.51	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	48.52	18.13	14.04	3.55	1.96	0.36	0.18	0.71	0.53	1.24
Pancreatic stromal cells, donor1	11249-116E7	25.10	8.17	8.68	1.26	1.26	0.34	1.18	0.59	0.25	0.59
Pericytes, donor1	11491-119E6	57.86	11.79	5.90	1.67	2.34	0.45	0.56	0.89	0.22	1.22
Pericytes, donor2	11571-120E5	48.67	12.00	8.38	2.26	2.26	1.13	1.58	1.36	0.68	1.13
Pericytes, donor3	11652-122E5	41.71	14.04	16.28	4.88	1.22	1.22	1.83	1.22	0.61	2.03
Perineurial Cells, donor1	11499-119F5	41.93	13.45	7.80	3.16	0.68	0.23	0.68	1.47	0.23	0.34
Perineurial Cells, donor2	11579-120F4	18.68	5.15	4.32	1.29	0.64	0.37	0.18	0.28	0.09	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	40.80	3.51	7.33	2.55	0.64	1.27	0.64	0.96	0.96	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	36.97	0.73	5.63	1.96	0.98	0.73	2.20	0.73	0.98	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	38.18	2.72	6.86	1.81	0.39	0.91	1.04	0.65	0.91	0.26
Placental Epithelial Cells, donor1	11278-116H9	32.29	7.17	6.94	2.87	0.72	0.00	0.00	0.96	0.24	0.48
Placental Epithelial Cells, donor2	11355-117H5	23.29	5.54	11.09	0.00	2.22	0.00	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	25.92	4.32	5.89	1.96	0.00	0.79	0.79	0.00	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	22.15	6.96	7.91	1.58	1.27	3.16	6.96	1.58	2.85	0.63
Preadipocyte - breast, donor1	11467-119B9	22.32	7.13	9.38	1.69	2.25	0.75	0.94	0.94	0.38	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	48.56	20.23	11.23	4.57	1.70	0.91	1.04	0.39	0.91	0.52
Preadipocyte - breast, donor2	11328-117E5	36.02	10.58	8.78	2.48	0.68	2.93	2.48	0.00	1.80	1.13
Preadipocyte - omental, donor1	11468-119C1	23.02	9.16	8.52	2.66	0.85	1.17	1.49	0.64	0.32	0.96
Preadipocyte - omental, donor2	11329-117E6	34.04	10.91	12.22	3.06	1.31	1.31	0.87	0.87	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	36.10	13.75	11.75	5.30	1.86	1.43	1.86	0.57	0.43	1.58
Preadipocyte - perirenal, donor1	11469-119C2	27.56	8.86	8.86	2.95	2.95	0.00	0.00	0.00	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	60.81	20.58	33.48	6.14	6.14	0.31	0.31	1.84	0.00	2.46
Preadipocyte - subcutaneous, donor2	11356-117H6	33.29	10.45	13.46	3.19	1.59	3.72	4.43	0.53	1.42	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	30.65	8.17	10.39	2.38	1.02	1.02	1.70	0.68	0.85	0.68
Preadipocyte - visceral, donor1	11280-116I2	32.79	11.27	12.57	2.98	1.30	0.09	1.02	1.21	0.09	1.30
Preadipocyte - visceral, donor2	11357-117H7	40.96	11.50	17.49	4.60	2.30	4.60	3.22	0.92	3.68	0.46
Preadipocyte - visceral, donor3	11429-118G7	22.47	8.67	8.57	1.99	1.25	1.36	1.67	0.84	1.67	1.46
Prostate Epithelial Cells (polarized), donor1	11253-116F2	24.44	5.43	2.87	0.75	0.45	0.60	1.21	0.75	0.30	0.15
Prostate Epithelial Cells, donor2	11331-117E8	21.80	8.67	11.65	3.11	0.95	1.35	2.44	0.27	0.68	1.90
Prostate Epithelial Cells, donor3	11404-118D9	35.15	3.49	3.06	1.84	0.12	1.78	2.02	0.61	0.55	0.12
Prostate Stromal Cells, donor1	11254-116F3	33.83	9.80	13.67	3.30	0.91	0.80	1.48	0.91	0.46	0.91
Prostate Stromal Cells, donor2	11332-117E9	27.25	8.07	11.48	3.59	0.36	1.61	2.33	1.08	0.72	1.26
Prostate Stromal Cells, donor3	11405-118E1	28.05	7.30	6.57	1.88	0.73	1.15	0.94	0.31	0.83	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	44.89	14.23	7.30	3.65	0.36	0.00	0.00	0.36	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	39.85	14.69	5.13	3.95	0.97	0.35	1.04	1.94	0.76	0.28
Renal Epithelial Cells, donor1	11517-119H5	35.51	15.72	6.09	4.06	2.54	0.00	0.00	1.01	0.00	1.01
Renal Epithelial Cells, donor2	11597-120H4	32.01	7.82	12.80	2.85	1.42	0.71	0.00	0.00	1.42	0.71
Renal Epithelial Cells, donor3	11678-122H4	39.28	15.88	7.41	1.06	1.06	0.95	1.06	1.38	0.74	0.85
Renal Glomerular Endothelial Cells, donor1	11514-119H2	21.79	4.77	7.49	1.36	1.36	0.00	2.04	0.00	1.36	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	15.77	4.45	7.55	1.35	0.94	1.35	0.54	0.13	0.40	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	15.54	7.99	6.44	2.89	1.11	0.44	0.22	0.22	0.89	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	29.94	15.97	9.32	5.99	0.67	0.00	1.33	0.00	0.00	2.00
Renal Mesangial Cells, donor1	11518-119H6	35.65	14.75	9.90	3.30	1.98	0.22	0.22	0.22	0.44	0.44
Renal Mesangial Cells, donor2	11598-120H5	26.33	6.90	6.27	1.88	1.25	0.63	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	34.68	15.54	6.94	3.61	1.11	0.55	0.83	0.28	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	28.99	8.05	9.13	1.88	0.27	0.27	0.00	0.54	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	18.98	4.64	5.90	4.22	0.42	0.42	0.84	0.42	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	26.81	11.19	6.94	4.05	1.74	1.35	0.00	0.96	0.96	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	41.23	9.33	4.15	4.15	0.52	0.78	1.56	2.07	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	41.78	11.65	10.52	5.40	0.28	0.57	1.14	0.57	0.00	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	34.99	12.35	10.29	3.09	1.03	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	37.64	6.52	7.28	1.51	0.25	0.25	2.76	2.01	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	43.03	5.61	5.48	2.54	0.40	1.20	0.53	1.07	0.67	1.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	25.02	4.47	10.72	8.04	2.68	2.68	1.79	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	28.07	9.91	7.15	5.50	3.30	4.95	8.81	0.00	3.30	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	42.34	17.40	15.66	6.96	4.06	2.32	2.90	0.58	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	53.05	14.69	12.09	7.54	3.38	0.65	1.04	0.91	0.91	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	54.42	15.00	14.90	10.63	3.87	2.48	2.38	0.99	1.79	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	61.68	16.62	21.75	10.04	3.46	0.22	0.45	1.12	0.56	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	75.05	23.44	17.86	10.79	3.72	2.73	2.85	2.73	1.24	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	65.50	16.67	14.10	7.81	3.61	3.85	2.45	1.63	2.91	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	70.96	22.65	16.18	10.17	5.32	4.39	3.70	1.16	1.62	1.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	31.08	13.01	13.96	7.80	2.33	1.78	2.19	1.64	1.23	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	65.35	12.25	15.43	9.83	2.87	2.42	4.84	1.36	2.27	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	56.27	16.49	17.02	10.03	5.20	0.18	0.54	1.25	0.90	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	42.03	20.37	14.20	8.75	3.73	1.43	2.44	1.00	0.57	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	64.71	17.38	14.70	9.77	4.29	2.90	2.90	1.50	2.68	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	60.19	17.26	16.60	7.08	3.10	0.66	1.33	1.33	1.33	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	26.38	13.76	15.10	7.26	2.87	1.53	0.96	0.38	1.15	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	59.81	14.35	13.14	9.22	3.07	1.58	2.05	1.12	1.21	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	59.94	19.54	20.86	8.08	3.76	1.13	1.13	0.38	0.56	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	40.61	14.86	14.47	9.95	2.92	1.33	0.66	0.80	0.80	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	63.27	15.87	15.28	9.83	4.19	1.75	1.75	1.07	1.07	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	64.35	18.14	19.48	8.59	3.63	1.91	1.91	0.57	1.34	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	37.48	17.30	13.14	6.41	3.31	1.28	0.96	0.96	0.43	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	58.02	15.70	17.38	8.97	1.68	1.40	3.92	2.52	3.64	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	57.76	16.58	17.60	8.37	4.79	2.73	1.03	0.34	1.03	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	37.01	13.67	14.04	8.57	1.28	0.91	1.28	1.46	0.36	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	64.50	15.45	14.59	10.55	3.68	2.58	3.31	1.10	2.08	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	69.71	17.86	17.86	9.27	4.16	1.34	2.69	1.88	1.61	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	23.35	19.11	15.10	7.78	4.72	2.12	3.30	1.42	1.42	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	54.96	17.26	16.07	7.34	3.17	3.57	3.37	1.39	3.37	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	57.06	11.69	16.14	12.16	5.85	1.87	1.87	1.40	1.17	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	32.55	12.86	15.55	6.01	3.73	0.41	3.11	1.87	1.24	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	53.09	13.49	15.26	9.29	4.20	4.42	3.98	2.21	3.76	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	57.23	11.49	17.55	8.77	1.67	1.04	2.51	1.04	1.25	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	41.18	14.40	16.69	8.21	4.04	1.88	2.96	2.02	0.94	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	50.75	14.13	15.33	11.75	2.04	0.17	1.19	0.17	1.19	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	64.01	19.09	17.35	13.69	4.05	2.12	0.77	0.96	1.35	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	26.99	16.33	15.47	8.77	3.09	1.38	3.95	0.34	0.86	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	54.87	14.13	17.83	8.78	3.98	0.69	0.55	0.41	0.69	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	58.44	14.61	18.72	10.51	5.09	3.78	3.28	0.99	2.46	2.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	30.68	15.51	15.85	8.69	3.41	1.19	1.87	0.85	1.36	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	69.98	16.72	13.76	7.84	3.99	2.96	0.74	1.04	1.63	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	51.98	15.73	23.72	9.86	3.47	0.53	0.00	0.80	1.07	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	48.81	12.31	9.40	6.78	3.46	1.24	1.66	1.38	1.11	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	69.29	17.62	10.00	9.05	3.10	1.67	3.10	1.19	1.90	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	72.15	19.55	19.75	10.68	4.03	1.61	1.01	2.02	1.61	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	49.16	19.31	13.18	7.44	5.84	1.79	3.77	1.70	0.85	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	74.06	13.63	18.17	9.78	4.19	4.89	3.14	0.70	2.45	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	51.07	14.20	13.60	7.56	1.21	0.60	0.60	1.21	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	44.18	17.01	12.85	7.10	7.96	2.57	2.94	1.35	0.73	1.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	75.54	23.29	26.78	9.32	4.95	1.31	0.58	2.18	0.73	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	66.93	16.43	16.43	10.95	1.83	3.04	3.04	0.61	0.61	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	31.35	17.18	15.07	6.03	3.92	0.90	1.21	0.30	0.30	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	65.82	15.61	13.12	10.86	6.11	3.62	2.71	1.13	1.81	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	79.98	21.87	15.58	8.69	4.19	2.10	1.50	2.10	1.50	1.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	55.49	20.19	10.51	5.20	4.37	1.89	3.66	2.24	0.94	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	69.16	21.77	15.58	6.19	4.91	2.77	0.64	4.06	1.92	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	67.31	18.03	17.43	5.41	5.41	4.81	0.60	0.60	1.20	1.20
Schwann Cells, donor1	11498-119F4	49.65	13.92	7.71	3.01	0.94	1.50	1.32	1.50	0.56	0.94
Schwann Cells, donor2	11578-120F3	30.62	3.40	0.00	0.00	0.00	0.00	0.00	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	21.25	6.57	6.13	1.53	2.41	0.88	1.31	0.66	1.10	0.88
Sebocyte, donor1	11220-116B5	66.83	12.60	8.76	2.19	1.64	1.10	0.00	0.00	0.55	1.10
Sebocyte, donor2	11301-117B5	20.68	6.43	4.14	1.38	0.00	1.38	1.84	0.00	1.38	0.46
Sebocyte, donor3	11378-118B1	26.18	7.21	5.98	1.03	0.21	1.24	0.62	0.21	0.62	0.21
Sertoli Cells, donor1	11255-116F4	41.41	18.22	13.25	8.28	1.66	1.66	1.66	0.00	1.66	1.66
Sertoli Cells, donor2	11333-117F1	25.42	8.47	5.65	0.00	0.00	2.82	0.00	2.82	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	45.57	10.21	7.04	3.08	0.44	0.44	0.97	1.85	0.18	0.70
Skeletal Muscle Cells, donor2	11358-117H8	37.59	7.23	6.51	2.17	0.00	0.00	0.72	1.45	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	54.34	24.25	14.21	10.03	3.34	1.67	0.00	0.00	2.51	1.67
Skeletal Muscle Cells, donor4	11451-119A2	20.74	4.56	4.71	1.41	0.79	0.31	0.47	0.31	0.31	0.63
Skeletal Muscle Cells, donor5	11455-119A6	15.90	2.23	3.42	1.78	0.15	0.74	0.74	0.30	0.59	0.15
Skeletal Muscle Cells, donor6	11459-119B1	22.93	4.31	5.54	1.54	0.77	1.69	0.92	0.46	0.77	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	33.77	7.06	3.53	0.76	1.39	0.50	0.88	1.39	0.00	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	27.82	7.71	6.85	1.00	0.71	2.00	1.14	0.71	1.00	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	29.66	5.56	6.05	2.38	0.99	0.60	1.09	0.50	0.89	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	21.65	6.32	5.73	1.85	1.10	0.42	0.17	0.84	0.00	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	57.18	10.13	11.58	4.34	2.17	0.72	0.00	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	23.67	7.71	8.12	3.03	1.10	0.28	0.00	1.10	0.83	1.24
Skin - palm, donor1	10286-104F7	32.23	0.00	10.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	11.39	6.05	5.91	1.30	0.72	1.01	0.43	0.43	0.43	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	26.17	18.81	22.90	2.45	1.64	2.45	1.64	1.64	0.82	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	11.42	3.64	4.02	1.43	0.26	0.91	1.43	0.91	0.78	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	28.50	11.12	7.92	2.09	0.42	0.70	1.53	1.11	0.28	1.25
Small Airway Epithelial Cells, donor2	11334-117F2	17.86	9.00	5.34	3.38	0.00	0.56	1.13	0.84	0.42	1.13
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	68.09	30.03	22.62	9.73	2.54	0.85	2.33	1.06	0.21	2.11
Small Airway Epithelial Cells, donor3	11406-118E2	31.78	7.20	8.32	4.12	0.37	0.90	0.75	0.37	0.52	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	16.05	18.52	18.82	5.86	3.39	4.01	9.87	1.54	1.23	3.39
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	26.90	20.90	11.78	4.00	2.00	1.11	2.22	0.22	0.44	3.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	78.18	35.86	29.39	8.23	1.18	0.00	0.00	1.18	0.59	3.53
Smooth Muscle Cells - Aortic, donor1	11283-116I5	39.56	13.48	19.01	3.54	2.43	0.44	0.44	1.33	0.00	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	53.55	29.53	26.78	9.06	1.97	1.58	0.79	1.58	0.39	3.94
Smooth Muscle Cells - Aortic, donor3	11432-118H1	59.49	40.17	32.45	10.04	3.09	0.77	0.00	2.32	0.00	7.73
Smooth Muscle Cells - Bladder, donor1	11519-119H7	30.02	5.00	2.00	2.00	1.00	2.00	2.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	62.28	23.55	27.01	9.58	2.53	1.33	0.93	1.60	0.00	4.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	47.66	17.07	13.52	3.32	2.44	1.99	3.77	1.33	1.99	2.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	32.78	13.96	20.48	4.23	1.92	0.77	0.38	1.02	1.02	3.84
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	27.68	8.14	11.72	1.95	0.33	0.00	0.98	0.00	0.98	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	33.08	7.68	9.45	2.95	0.00	0.30	0.00	0.59	0.30	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	29.04	7.83	10.53	3.70	1.42	0.28	0.43	0.57	0.43	1.85
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	40.34	13.66	12.04	3.58	1.63	0.98	0.33	1.14	0.16	1.30
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	23.14	6.09	4.26	0.91	0.00	0.61	0.30	0.61	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	61.12	15.15	14.65	4.04	2.53	0.25	0.51	1.77	0.25	1.52
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	18.36	18.36	6.12	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	44.82	24.32	14.78	10.97	1.43	2.86	0.95	0.95	0.48	3.81
Smooth Muscle Cells - Colonic, donor1	11239-116D6	26.10	5.75	6.05	1.62	0.29	0.15	0.29	0.88	0.15	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	20.88	5.81	6.67	1.29	0.22	0.43	1.94	0.43	0.22	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	26.03	6.09	6.19	1.99	1.99	0.63	0.21	0.52	0.42	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	61.41	28.15	29.39	10.05	2.94	0.62	0.77	1.70	0.46	4.95
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	50.66	20.48	24.79	7.55	2.16	2.16	2.16	4.31	0.00	6.47
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	34.07	13.15	10.16	4.48	1.49	0.90	0.30	0.30	0.90	1.49
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	19.80	0.68	11.27	1.02	0.34	0.68	0.34	1.71	0.00	2.05
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	13.66	0.55	4.87	0.55	0.08	0.31	0.55	0.55	0.39	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	45.99	21.94	22.95	4.83	3.22	2.11	2.42	0.91	1.11	2.01
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	46.19	18.43	14.11	4.10	2.28	1.37	3.41	1.14	1.82	1.37
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	43.47	19.93	10.87	5.43	3.62	4.83	3.62	1.81	4.83	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	34.18	10.33	10.33	2.38	1.06	0.00	0.53	0.53	0.00	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	21.17	6.26	7.72	1.46	0.80	0.27	1.46	1.20	0.40	1.86
Smooth Muscle Cells - Prostate, donor2	11335-117F3	28.68	9.02	8.77	3.13	0.75	1.75	1.38	0.75	0.88	1.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	19.02	4.82	3.04	2.54	1.27	0.00	1.01	0.51	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	55.03	17.64	18.85	4.82	1.96	0.90	0.30	2.41	0.60	2.11
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	44.26	10.50	12.00	2.25	1.50	3.00	0.00	0.75	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	19.38	1.29	11.63	0.00	24.55	2.58	0.00	1.29	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	84.64	45.58	33.49	5.58	6.51	2.33	0.93	4.65	0.47	3.72
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	61.09	16.66	23.22	4.04	1.51	3.03	2.02	2.02	2.02	2.52
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	33.85	16.61	12.85	4.70	3.45	3.13	0.94	0.94	0.63	3.13
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	17.11	2.65	12.68	0.59	1.18	0.00	0.88	1.47	0.29	1.47
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	13.75	1.42	10.33	1.00	0.58	0.00	0.08	0.25	0.25	1.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	8.41	0.47	5.61	0.47	0.47	0.93	0.47	0.47	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	60.30	28.78	26.91	8.35	3.45	0.58	0.58	1.73	0.29	4.89
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	59.66	15.55	21.67	7.14	3.57	1.02	1.78	1.53	2.04	3.06
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	20.87	12.97	12.60	5.08	1.32	1.69	0.38	0.94	0.94	1.69
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	29.21	10.62	4.89	2.38	1.54	0.84	0.56	1.26	0.00	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	30.83	10.22	7.04	1.76	1.34	0.08	1.01	0.59	0.08	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	35.71	5.71	6.67	3.81	0.00	2.86	0.00	1.43	0.95	1.43
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	66.79	26.91	23.49	10.52	2.69	0.49	0.49	1.22	0.98	3.18
Smooth Muscle Cells - Uterine, donor1	11258-116F7	26.51	13.04	12.37	3.31	2.65	1.33	0.88	0.22	0.22	3.54
Smooth Muscle Cells - Uterine, donor3	11466-119B8	34.23	9.95	10.83	2.34	1.46	0.00	0.59	1.46	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	15.16	5.44	3.30	0.58	0.39	0.97	0.97	0.19	0.97	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	10.58	6.08	9.52	2.91	0.26	1.85	1.32	0.26	0.53	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	13.39	5.95	1.86	0.74	0.74	1.12	2.60	1.12	1.49	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	24.79	5.75	12.94	4.31	3.95	1.44	2.52	1.08	1.80	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	16.75	11.07	16.47	4.26	0.85	1.14	1.42	1.14	0.28	3.12
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	8.67	9.06	11.82	3.54	1.97	0.39	1.97	1.18	1.18	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	18.03	3.05	4.57	1.02	0.25	1.27	4.57	0.51	1.52	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	16.77	2.00	1.20	0.80	0.40	0.40	0.00	0.80	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	11.29	2.93	5.85	0.42	0.42	1.67	2.51	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	2.75	0.46	5.96	0.46	0.00	0.00	0.00	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	30.63	12.62	10.27	2.86	1.51	0.34	1.68	1.18	0.00	1.01
Synoviocyte, donor2	11368-117I9	28.33	5.36	5.36	1.68	0.34	0.67	0.50	0.50	0.50	0.00
Synoviocyte, donor3	11440-118H9	17.43	3.35	2.90	1.34	0.67	1.12	0.89	0.89	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	46.81	14.29	9.65	3.93	1.79	0.00	0.00	2.14	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	43.60	9.91	15.86	1.98	0.00	1.98	0.00	1.98	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	43.76	13.20	12.50	3.70	0.46	1.62	0.69	0.69	0.46	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	25.66	4.37	3.58	1.65	0.29	0.36	0.07	0.22	0.07	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	28.22	6.57	6.57	2.71	0.00	0.39	0.39	0.77	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	27.49	5.73	8.02	1.15	0.00	0.57	0.00	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	43.67	6.40	6.89	3.08	0.86	0.74	0.62	0.74	0.86	0.37
Urethra, donor2	10319-105A4	26.98	10.79	14.39	1.80	1.80	0.00	1.80	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	28.43	9.83	10.63	4.25	0.80	1.06	0.53	1.06	1.06	1.59
Urothelial Cells, donor2	11600-120H7	27.64	6.41	7.61	2.40	0.00	0.80	0.40	1.20	0.00	0.00
Urothelial Cells, donor3	11681-122H7	27.50	5.96	4.81	2.29	0.23	0.69	0.92	0.46	0.23	0.69
Urothelial cells, donor0	11216-116B1	51.93	11.37	5.80	3.12	0.45	0.89	0.22	1.34	0.22	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	88.09	2.67	10.68	0.89	0.00	0.89	0.89	1.78	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	94.35	4.29	15.73	1.43	0.00	0.00	0.00	1.43	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	87.62	4.11	8.90	2.05	0.68	2.74	2.05	0.68	2.74	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	55.44	3.44	8.61	3.10	0.69	0.34	1.03	0.69	1.72	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	41.83	1.74	6.97	1.74	0.58	0.58	0.58	1.16	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	108.29	4.16	10.41	1.04	1.04	1.04	1.04	0.00	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	88.11	6.42	9.18	0.92	0.92	1.84	5.51	0.00	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	72.12	2.74	10.04	1.83	0.00	2.74	0.00	0.91	1.83	0.91
Wilms' tumor cell line:G-401	10809-111A8	20.35	4.32	4.69	2.22	0.49	0.99	0.99	0.49	0.49	0.25
Wilms' tumor cell line:HFWT	10597-108E3	37.84	9.68	21.12	7.04	0.00	0.00	0.00	0.00	1.76	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	21.51	1.96	5.87	1.12	0.00	0.28	0.56	0.28	0.00	0.00
achilles tendon, donor2	10292-104G4	33.06	4.13	6.20	0.00	2.07	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	28.05	5.35	6.88	1.27	0.00	0.76	1.27	0.51	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	28.79	4.88	6.73	3.95	0.23	0.23	0.46	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	51.52	2.97	12.11	4.27	0.71	1.07	0.59	0.71	0.47	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	47.62	6.53	11.70	4.35	1.09	0.54	0.54	0.27	0.82	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	12.09	0.28	1.97	0.56	0.00	0.56	1.41	0.00	0.28	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	20.94	1.27	2.96	2.33	0.21	0.21	0.00	0.42	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	27.49	7.35	6.26	4.63	1.09	1.36	0.27	0.82	0.82	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	16.74	1.32	4.41	1.32	0.44	0.00	0.00	0.88	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	11.43	1.63	3.27	0.00	0.00	0.00	0.00	0.41	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	45.04	3.49	10.87	3.49	0.39	0.78	0.39	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	4.05	0.18	0.92	0.18	0.18	0.37	0.00	0.18	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	11.70	7.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	17.20	2.32	1.39	1.63	0.23	0.93	0.23	0.23	0.93	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	17.61	2.85	7.77	3.37	1.29	0.00	0.52	0.52	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	10.52	0.58	2.92	1.17	0.00	0.58	0.88	0.00	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	12.08	0.00	3.25	0.93	0.00	0.00	0.46	0.00	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	13.16	4.94	3.29	1.23	0.00	0.41	0.00	0.00	0.41	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	4.91	0.31	2.15	1.23	0.00	0.00	0.31	0.00	0.31	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	16.21	2.56	2.99	1.71	0.43	0.00	0.43	0.00	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	23.05	0.91	3.64	1.21	0.30	0.61	0.30	0.30	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	15.89	2.17	5.30	2.17	0.24	0.48	0.00	0.48	0.24	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	7.57	1.34	3.56	0.89	0.00	0.45	0.22	0.00	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	16.01	2.00	4.67	0.33	0.00	0.00	0.00	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	22.30	3.72	1.86	1.86	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	19.96	2.26	3.77	0.75	0.00	0.75	0.00	0.00	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	20.50	1.74	3.49	1.74	0.44	0.00	0.44	0.44	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	1.87	3.75	0.00	0.00	0.00	0.00	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	19.31	1.88	10.13	1.65	0.24	0.47	0.24	0.71	0.24	0.47
adipose tissue, adult, pool1	10010-101C1	31.80	2.79	6.83	2.02	0.78	1.24	0.93	0.62	0.31	0.31
adipose, donor1	10184-103D4	76.23	25.22	6.45	8.21	0.00	2.35	15.25	2.35	2.35	0.00
adipose, donor2	10185-103D5	49.47	8.11	7.30	1.22	0.00	1.22	7.70	0.81	0.41	0.41
adipose, donor3	10186-103D6	33.22	10.89	4.63	2.18	1.63	1.63	8.71	1.36	0.27	0.00
adipose, donor4	10187-103D7	22.54	7.80	2.60	4.33	0.87	1.73	2.60	0.87	2.60	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	86.64	11.68	5.68	6.31	0.32	0.47	0.79	1.10	0.63	0.95
adrenal gland, adult, pool1	10081-102A9	21.83	3.64	7.28	7.28	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	43.09	5.07	4.94	1.47	0.27	0.53	0.40	0.93	0.27	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	23.58	5.72	10.72	3.57	1.07	0.36	0.36	0.36	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	37.79	1.85	4.64	1.39	0.70	0.46	0.93	0.70	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	25.02	1.69	3.72	2.37	0.00	0.00	0.34	0.00	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	39.48	1.47	6.19	0.59	0.59	0.59	0.59	0.59	0.59	0.00
amygdala - adult, donor10196	10167-103B5	163.64	157.71	35.57	11.86	28.46	16.60	7.11	4.74	9.49	2.37
amygdala, adult, donor10252	10151-102I7	258.12	84.55	24.13	8.92	10.95	5.27	3.24	2.23	9.33	2.64
amygdala, newborn, donor10223	10360-105E9	79.72	59.71	27.44	6.46	13.88	4.84	2.90	2.58	2.26	3.23
anaplastic carcinoma cell line:8305C	10428-106D5	82.38	9.04	6.24	3.06	1.15	1.15	1.40	1.78	0.64	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	30.45	6.62	6.62	2.21	0.44	0.00	0.66	0.66	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	77.83	10.36	4.68	2.34	0.67	1.67	0.67	0.00	0.33	0.33
aorta, adult, pool1	10052-101G7	40.60	3.14	5.10	1.37	0.98	1.37	1.37	0.20	0.78	0.00
appendix, adult	10189-103D9	51.23	3.10	7.76	2.72	0.39	1.16	0.78	0.00	1.16	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	46.43	6.88	5.16	1.72	1.38	1.72	1.38	1.72	0.00	0.00
artery, adult	10190-103E1	35.33	0.00	4.08	1.36	0.00	2.72	1.36	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	61.28	15.79	3.04	2.32	1.88	0.58	1.30	0.58	0.87	0.14
b cell line:RPMI1788	10427-106D4	35.69	2.97	1.64	1.04	0.00	0.00	0.74	0.30	0.45	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	47.17	21.64	18.03	6.38	3.05	1.11	3.05	0.28	0.55	4.44
bile duct carcinoma cell line:HuCCT1	10432-106D9	52.69	5.85	8.14	5.66	0.00	0.89	0.60	0.69	0.40	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	8.87	0.50	0.84	0.84	0.00	0.67	0.17	0.00	0.50	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	15.66	0.00	3.36	1.68	0.00	0.56	0.56	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	53.02	3.80	4.56	1.85	0.54	1.09	0.76	0.76	0.22	0.22
blood, adult, pool1	10053-101G8	28.79	2.21	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	19.70	10.28	7.71	0.86	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	43.86	4.05	7.42	2.02	2.02	2.02	2.70	0.00	1.35	0.67
brain, adult, donor1	10084-102B3	190.66	64.58	27.68	4.10	15.38	9.23	9.23	2.05	6.15	0.00
brain, adult, pool1	10012-101C3	301.00	116.59	27.95	7.57	24.16	6.46	7.35	6.68	5.12	2.45
brain, fetal, pool1	10085-102B4	296.53	162.96	40.07	2.67	10.69	5.34	8.01	8.01	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	41.63	4.29	12.55	2.31	0.33	1.65	0.33	0.99	1.32	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	179.62	20.72	35.95	9.74	1.25	1.12	1.75	3.00	1.50	1.12
breast, adult, donor1	10080-102A8	18.31	1.26	3.79	3.16	0.63	2.53	0.00	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	12.45	2.54	4.83	1.91	0.13	0.51	0.51	0.51	0.38	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	37.11	9.59	5.26	2.78	1.55	0.62	0.31	0.93	0.62	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	32.92	2.76	1.84	1.15	0.69	2.76	4.37	0.46	1.61	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	12.59	2.42	11.38	2.18	0.24	1.21	0.00	0.48	0.24	0.48
carcinoid cell line:NCI-H1770	10703-109H1	70.53	5.64	11.75	7.99	0.47	1.41	1.41	0.00	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	43.31	6.13	5.80	2.52	0.77	0.33	0.44	0.44	0.22	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	36.76	7.61	7.29	3.80	0.95	0.95	2.22	0.00	1.27	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	110.20	27.15	33.01	11.71	2.40	4.79	1.86	2.93	2.93	1.86
caudate nucleus - adult, donor10196	10177-103C6	116.28	56.41	21.88	5.76	8.06	8.06	2.30	2.30	8.06	1.15
caudate nucleus, adult, donor10252	10164-103B2	242.46	77.47	20.58	4.18	6.36	6.02	2.68	2.01	5.69	1.51
caudate nucleus, adult, donor10258	10379-105H1	158.94	68.77	28.27	5.35	10.70	5.35	3.82	5.35	4.58	1.53
caudate nucleus, newborn, donor10223	10354-105E3	90.09	41.38	27.83	4.76	4.03	3.30	3.30	6.59	3.66	4.39
cerebellum - adult, donor10196	10173-103C2	233.06	90.31	14.57	2.91	17.48	11.65	11.65	2.91	5.83	5.83
cerebellum, adult, donor10252	10166-103B4	377.06	58.29	12.81	5.76	10.25	11.32	3.42	3.63	9.18	0.43
cerebellum, adult, pool1	10083-102B2	174.89	33.11	10.00	6.55	7.24	5.52	5.17	3.45	3.10	0.34
cerebellum, newborn, donor10223	10357-105E6	117.07	40.68	26.57	4.98	5.81	4.15	5.81	0.83	2.49	0.00
cerebral meninges, adult	10188-103D8	259.70	86.74	30.00	11.85	16.39	3.78	5.55	1.76	4.29	1.51
cerebrospinal fluid, donor2	10294-104G6	34.35	8.04	8.77	0.73	0.73	0.73	0.73	0.00	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	27.61	1.01	2.88	0.72	0.00	0.29	0.14	0.86	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	39.11	3.81	6.79	3.48	0.00	0.33	0.50	0.99	0.83	0.00
cervix, adult, pool1	10013-101C4	62.15	4.93	4.93	1.36	0.84	1.68	0.94	1.26	0.42	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	70.78	22.99	27.73	13.93	2.37	0.70	1.39	1.81	0.98	3.48
chondrosarcoma cell line:SW 1353	10700-109G7	15.68	1.31	5.23	0.00	0.00	0.00	0.00	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	31.94	2.11	4.10	3.60	0.12	0.50	0.62	0.75	0.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	14.42	2.34	0.74	1.36	0.00	0.12	0.25	0.12	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	22.53	2.37	2.37	2.13	0.00	0.00	0.24	0.24	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	37.61	3.13	2.56	1.42	0.85	0.28	0.85	1.42	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	37.68	9.64	9.25	3.38	0.89	1.49	0.99	0.50	0.60	0.70
chorionic membrane cells, donor3	12240-129G8	25.28	4.95	2.75	0.55	0.00	1.65	2.75	0.55	1.65	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	8.08	1.01	4.04	1.01	0.00	2.02	2.02	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	16.52	0.96	3.46	1.15	0.38	0.19	0.38	0.77	0.38	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	7.18	0.63	2.32	1.69	0.00	0.00	0.42	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	16.18	1.80	6.68	1.28	0.00	0.51	0.51	0.00	0.77	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	19.83	2.66	6.05	1.21	0.00	0.48	0.00	0.48	0.48	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	20.77	3.87	6.92	3.46	0.20	0.41	0.20	0.20	0.61	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	18.85	1.18	2.36	1.47	0.00	0.29	0.00	0.00	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	14.33	1.82	2.35	0.52	0.00	0.26	0.26	0.26	0.26	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	34.06	5.71	0.91	1.14	0.23	1.37	2.51	0.69	1.60	0.23
clear cell carcinoma cell line:TEN	10636-108I6	35.40	3.64	4.68	2.08	0.00	0.69	0.87	0.35	1.21	0.17
colon carcinoma cell line:CACO-2	10513-107D9	14.09	4.39	4.21	3.66	0.37	0.00	0.37	0.18	0.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	64.99	4.18	5.32	3.80	0.00	0.00	1.14	0.76	0.38	0.00
colon, adult, donor1	10082-102B1	20.23	4.76	3.57	1.19	1.19	0.00	0.00	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	36.31	2.70	5.52	1.18	0.59	0.47	0.24	0.24	0.24	0.12
colon, fetal, donor1	10070-101I7	20.39	4.94	2.47	1.85	0.00	0.62	0.62	0.00	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	59.59	0.00	13.75	22.92	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	32.72	9.77	14.45	7.65	1.70	0.42	0.85	0.85	0.00	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	24.60	6.94	9.06	2.11	1.21	0.45	0.60	0.60	0.15	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	27.92	8.60	10.86	1.97	1.83	0.56	1.13	0.14	0.28	0.28
corpus callosum, adult, pool1	10042-101F6	344.62	74.52	23.66	7.96	5.53	3.98	2.32	8.07	2.99	0.88
cruciate ligament, donor2	10295-104G7	31.61	0.81	8.10	0.81	0.00	1.62	0.00	0.00	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	25.68	4.01	2.41	0.80	0.80	1.61	0.00	0.80	0.00	0.00
diencephalon, adult	10193-103E4	156.47	64.32	33.60	5.52	3.60	5.52	5.28	2.40	5.04	1.68
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	46.61	2.30	9.87	1.61	0.23	3.90	4.13	1.61	2.30	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	40.77	4.36	5.64	2.56	0.26	0.00	0.00	1.54	0.26	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	26.24	10.83	5.30	3.37	0.48	0.72	0.48	0.24	0.24	0.00
ductus deferens, adult	10196-103E7	40.86	2.99	4.98	1.99	0.00	2.99	1.50	0.50	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	18.72	2.88	8.64	0.00	1.44	0.00	0.00	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	39.73	8.09	8.09	2.21	0.74	4.41	2.21	0.00	2.21	0.00
dura mater, adult, donor1	10041-101F5	41.29	7.02	6.77	1.40	0.66	0.41	0.50	0.50	0.33	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	33.09	19.54	6.66	6.44	0.44	0.44	1.55	0.44	0.00	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	40.84	15.19	17.48	7.59	0.72	0.86	0.86	1.86	0.43	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	21.58	5.55	3.70	0.62	0.00	0.00	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	33.30	3.94	2.72	0.61	0.61	0.30	0.61	0.30	0.91	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	24.70	4.32	3.09	1.85	0.62	0.00	0.00	0.00	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	23.64	5.25	2.63	1.31	0.00	1.31	0.00	0.00	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	19.44	5.36	2.01	1.34	1.01	0.00	0.67	0.67	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	58.72	13.77	6.16	3.44	0.36	0.54	0.72	0.91	0.54	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	35.06	6.11	7.08	1.93	0.32	1.29	2.25	0.80	1.61	0.64
epidermoid carcinoma cell line:A431	10426-106D3	25.01	2.67	5.56	2.00	0.22	0.11	0.11	0.33	0.44	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	17.27	0.55	7.48	2.53	0.11	0.11	0.22	0.66	0.33	0.22
epididymis, adult	10197-103E8	33.91	2.30	4.81	1.88	0.63	1.26	1.05	1.67	1.67	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	36.55	6.21	6.56	1.60	0.18	1.24	0.35	1.06	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	9.44	2.75	3.15	1.18	0.00	0.00	0.39	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	28.57	3.93	5.50	2.75	0.13	0.79	1.44	1.05	0.92	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	29.43	3.25	4.33	3.94	0.10	1.28	0.89	0.39	0.69	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	26.55	2.13	6.27	2.58	0.00	0.56	0.56	0.56	0.56	0.22
esophagus, adult, pool1	10015-101C6	37.48	3.40	6.48	2.02	0.42	0.96	0.74	0.96	0.11	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	49.72	5.64	8.77	0.88	0.50	0.25	0.63	0.63	1.00	0.25
eye - muscle inferior rectus, donor1	10272-104E2	60.36	2.41	4.83	2.41	0.00	4.83	0.00	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	27.35	0.00	2.10	0.00	0.00	2.10	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	40.18	5.95	1.49	0.00	2.98	0.00	0.00	0.00	0.00	1.49
eye - muscle superior, donor2	10297-104G9	38.98	4.59	6.88	1.15	0.00	0.00	0.00	1.15	3.44	0.00
eye - vitreous humor, donor1	10268-104D7	53.92	4.37	7.29	0.00	0.00	0.00	0.00	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	84.41	13.73	4.07	1.02	1.27	3.05	3.81	1.27	2.80	1.27
fibrosarcoma cell line:HT-1080	10758-110E2	18.34	3.46	2.56	1.67	0.00	0.26	0.38	0.00	0.00	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	22.79	6.65	4.99	4.27	0.00	0.24	0.71	0.24	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	355.69	171.13	42.22	10.60	49.16	3.75	3.47	8.07	1.97	3.66
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	18.32	2.70	5.70	3.00	0.30	0.30	0.60	0.30	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	39.87	4.39	3.57	1.19	0.09	0.09	0.09	0.27	0.27	0.18
gall bladder, adult	10198-103E9	55.29	6.52	6.76	2.90	0.97	0.72	0.24	0.48	0.00	0.48
gamma delta positive T cells, donor1	11937-126A2	51.00	3.22	8.05	1.61	1.07	0.54	1.07	1.61	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	35.11	1.12	4.86	1.12	0.75	1.12	0.37	0.37	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	26.40	5.91	9.50	5.07	1.06	0.42	1.06	1.27	1.48	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	33.46	1.55	4.06	1.16	0.00	0.39	0.00	0.77	0.19	0.19
gastric cancer cell line:AZ521	10549-107H9	25.25	9.02	1.80	1.31	0.49	0.16	0.33	0.66	0.33	0.33
gastric cancer cell line:GSS	10560-108A2	32.95	2.75	8.24	0.00	0.00	0.00	0.92	0.92	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	49.12	20.79	6.85	2.28	1.14	3.43	2.51	1.14	1.37	0.46
giant cell carcinoma cell line:LU65	10487-107B1	19.85	0.92	2.87	1.26	0.00	0.57	0.11	0.57	0.34	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	37.65	4.76	6.16	2.52	0.70	0.70	0.56	0.84	0.28	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	22.20	3.24	4.74	4.49	0.25	0.25	0.75	1.00	1.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	36.10	17.63	25.02	7.18	2.96	0.53	0.74	1.27	0.84	2.01
glioblastoma cell line:A172, tech_rep2	10444-106F3	37.22	20.78	31.88	7.58	1.69	0.42	0.42	0.84	0.42	1.97
glioblastoma cell line:T98G	10485-107A8	22.96	4.19	6.40	1.10	0.55	0.22	0.99	0.33	0.11	0.22
glioma cell line:GI-1	10413-106B8	38.37	13.77	7.03	2.34	0.88	0.00	1.76	0.59	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	91.11	39.36	26.97	2.92	6.56	2.92	0.73	2.19	1.46	1.46
globus pallidus, adult, donor10252	10161-103A8	241.65	35.88	15.87	3.66	4.64	8.06	2.20	1.71	5.13	1.22
globus pallidus, adult, donor10258	10367-105F7	153.35	36.97	19.17	1.37	2.74	8.22	5.48	5.48	6.85	2.74
globus pallidus, newborn, donor10223	10364-105F4	67.15	20.78	19.72	7.99	3.20	0.53	1.07	1.60	2.66	2.13
granulocyte macrophage progenitor, donor1	12131-128D7	31.81	4.89	31.81	17.13	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	31.36	7.04	3.84	2.56	0.96	0.00	0.64	0.64	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	10.10	4.59	3.67	3.67	0.46	1.38	0.00	0.46	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	9.15	7.32	3.66	2.74	1.83	0.46	0.46	0.46	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	6.44	2.58	2.58	1.93	0.64	0.64	0.64	0.00	0.64	0.00
hIPS, biol_rep1	14380-156B6	2.87	1.44	1.44	0.00	0.00	1.44	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	4.12	5.49	3.43	4.80	0.69	0.69	0.69	0.69	0.69	0.00
hIPS, biol_rep3	14382-156B8	72.83	37.52	29.79	5.52	6.62	8.83	1.10	3.31	5.52	0.00
hairy cell leukemia cell line:Mo	10712-109I1	33.91	7.18	7.47	1.15	1.15	2.30	0.57	0.29	0.00	0.00
heart - mitral valve, adult	10205-103F7	44.55	8.97	4.48	2.39	1.49	1.79	0.90	0.30	0.60	0.30
heart - pulmonic valve, adult	10206-103F8	58.57	3.66	4.71	2.61	0.52	1.57	0.26	0.26	1.57	0.00
heart - tricuspid valve, adult	10207-103F9	35.80	4.16	8.33	3.33	0.00	0.00	0.83	0.00	0.00	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	40.20	3.88	4.49	2.24	0.82	1.22	0.82	0.41	0.61	0.61
heart, adult, diseased, donor1	10051-101G6	67.28	4.26	3.41	2.98	0.85	1.70	1.28	0.85	1.28	0.00
heart, adult, pool1	10016-101C7	47.38	1.15	5.52	1.84	0.23	0.23	0.23	0.23	0.23	0.23
heart, fetal, pool1	10046-101G1	83.07	7.50	3.59	3.29	0.82	0.21	0.51	0.92	0.51	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	41.96	18.51	6.17	2.16	1.23	1.54	0.31	0.62	0.93	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	13.08	5.95	3.57	1.19	0.00	0.00	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	13.37	3.09	2.65	1.33	0.33	0.66	0.33	0.22	0.11	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	14.08	2.06	0.97	1.46	0.73	0.73	0.36	0.24	0.12	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	14.55	3.13	2.22	1.62	0.30	0.40	0.20	0.10	0.20	0.00
hepatoma cell line:Li-7	10484-107A7	31.70	5.34	5.89	2.89	0.11	0.44	0.78	1.00	0.22	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	12.06	1.01	2.91	1.21	0.00	0.20	0.00	0.10	0.00	0.10
hippocampus - adult, donor10196	10169-103B7	121.13	94.63	28.39	9.46	19.87	1.89	3.79	0.95	6.62	3.79
hippocampus, adult, donor10252	10153-102I9	237.37	68.58	20.41	7.35	10.82	8.78	4.08	4.08	7.14	0.61
hippocampus, adult, donor10258	10374-105G5	76.19	94.11	44.82	5.48	24.40	7.47	1.99	2.49	3.49	3.49
hippocampus, newborn, donor10223	10363-105F3	104.33	68.38	35.25	7.75	11.63	3.52	3.17	3.17	1.41	3.88
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	42.72	10.38	4.88	1.22	0.61	1.83	6.10	1.83	3.66	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	22.38	5.11	3.53	4.12	0.39	1.18	1.18	0.79	0.59	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	24.12	5.84	3.30	3.81	0.00	1.52	1.27	0.51	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	45.67	3.38	1.13	7.33	0.56	1.69	5.64	1.69	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	44.15	9.04	5.16	5.68	0.00	6.71	13.43	3.87	1.55	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	63.02	7.59	6.07	3.04	0.00	2.28	5.69	1.14	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	47.88	20.44	8.47	1.75	1.46	0.88	8.17	2.04	2.04	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	65.49	21.97	5.60	2.15	0.65	4.09	8.62	3.23	1.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	48.38	21.27	8.34	3.75	1.67	3.34	2.50	2.09	1.25	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	59.20	25.57	9.00	5.92	1.89	1.18	2.13	0.71	0.24	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	46.45	17.36	7.39	3.70	1.61	2.25	6.11	1.45	0.96	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	39.05	20.87	9.43	5.39	2.69	0.67	0.67	1.35	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	20.81	4.54	3.13	3.29	0.78	0.94	0.94	0.78	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	15.72	4.42	3.93	2.95	0.00	1.97	5.40	2.46	0.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	22.69	0.87	5.24	0.87	0.00	0.00	3.49	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	57.08	9.93	6.87	6.68	0.57	2.67	5.15	1.72	1.53	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	44.92	11.77	6.54	5.67	0.44	3.92	3.92	0.87	0.87	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	49.98	8.00	8.50	1.50	1.00	0.50	7.50	1.00	2.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	82.14	17.14	6.03	3.01	1.13	3.96	9.80	2.26	2.83	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	72.75	16.82	5.00	1.82	1.82	2.27	9.09	4.55	2.27	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	54.82	10.34	5.33	2.82	0.63	2.82	8.46	2.19	0.31	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	43.60	21.88	7.68	4.57	0.82	3.43	4.41	2.12	0.98	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	53.42	21.48	4.94	3.48	2.61	3.19	6.10	1.74	1.74	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	47.23	18.53	8.37	2.99	0.00	2.09	6.58	1.49	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	24.20	5.91	5.36	4.25	0.18	1.85	2.40	1.11	0.92	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	20.83	5.99	3.99	3.71	0.57	1.14	1.43	1.43	1.43	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	26.13	9.39	3.67	2.45	0.00	0.82	2.45	1.22	0.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	45.77	13.73	7.75	5.63	0.70	4.22	8.80	2.11	2.82	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	37.69	10.77	8.87	6.02	0.32	2.85	6.33	1.90	0.95	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	39.04	12.71	5.45	5.14	0.61	2.12	7.26	2.12	1.21	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	62.57	21.20	7.24	2.07	2.59	1.55	5.17	2.07	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	34.54	15.94	8.63	1.99	1.33	0.66	5.31	1.33	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	47.46	16.67	7.44	3.08	1.54	1.54	5.13	1.28	0.77	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	49.60	20.20	3.83	3.58	2.30	6.39	7.93	1.79	2.30	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	40.89	28.77	3.79	3.79	0.00	1.51	4.54	3.03	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	26.55	16.13	9.75	4.37	0.67	2.02	4.37	2.02	1.68	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	22.94	4.83	5.07	3.86	0.24	1.45	1.69	0.24	0.24	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	13.82	6.68	4.46	3.12	0.00	0.45	4.46	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	26.83	10.24	5.37	4.88	0.49	0.00	2.44	0.49	0.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	61.73	11.00	4.28	6.42	0.61	2.75	7.03	1.83	1.83	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	100.85	13.01	6.51	13.01	0.00	0.00	39.04	3.25	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	63.87	9.93	4.96	4.30	0.33	3.64	8.60	2.32	0.99	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	48.16	19.16	6.57	7.66	1.09	1.64	4.38	2.19	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	46.68	17.01	6.88	3.26	1.09	1.45	3.26	2.17	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	53.02	14.59	3.91	3.20	1.78	2.49	3.20	1.07	0.71	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	33.41	8.35	14.32	2.39	1.19	3.58	7.16	1.19	1.19	5.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	61.75	36.16	8.13	4.20	1.63	0.81	6.77	1.49	0.54	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	28.02	17.24	6.73	4.04	0.81	1.08	3.50	0.81	0.54	0.81
immature langerhans cells, donor1	11904-125F5	15.98	2.42	7.99	1.70	1.94	0.24	0.48	0.24	0.00	0.24
immature langerhans cells, donor2	11905-125F6	22.18	0.79	3.17	2.38	5.54	0.00	0.00	0.00	0.00	0.79
insula, adult, pool1	10039-101F3	391.03	194.57	54.60	14.67	56.50	4.35	3.79	9.27	1.61	4.54
keratoacanthoma cell line:HKA-1	10791-110H8	20.48	3.25	10.40	1.95	0.33	0.33	1.30	0.00	0.33	0.98
kidney, adult, pool1	10017-101C8	44.46	5.31	8.81	2.40	0.70	0.70	0.80	1.20	1.00	0.40
kidney, fetal, pool1	10045-101F9	66.14	8.35	3.54	1.98	0.78	0.64	0.42	1.34	0.42	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	76.98	13.49	8.24	5.96	1.14	0.43	0.85	1.14	0.43	0.99
large cell lung carcinoma cell line:NCI-H460	10839-111E2	42.03	4.15	4.70	1.38	0.00	0.55	1.52	1.24	0.83	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	44.77	7.34	10.28	5.69	0.18	0.18	0.55	0.37	0.18	0.92
left atrium, adult, donor1	10079-102A7	19.07	1.09	1.09	0.54	0.00	1.63	0.00	0.00	0.54	0.00
left ventricle, adult, donor1	10078-102A6	22.75	1.01	3.54	1.01	0.00	1.01	0.51	0.51	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	31.74	8.21	18.33	1.64	1.37	0.27	0.27	0.00	0.27	0.55
leiomyoma cell line:10964C	10569-108B2	22.63	8.98	8.62	3.95	1.80	1.08	2.87	1.44	1.44	1.08
leiomyoma cell line:15242A	10570-108B3	26.63	13.04	15.22	3.80	2.17	0.00	1.09	3.26	1.63	1.63
leiomyoma cell line:15425	10571-108B4	28.90	13.84	12.87	3.89	1.46	3.40	3.89	1.21	3.40	1.94
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	25.40	6.35	6.35	0.00	0.00	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	5.23	25.09	4.18	0.00	0.00	0.00	1.05	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	23.49	7.20	3.78	1.06	0.59	0.35	0.12	0.24	0.35	0.12
liposarcoma cell line:KMLS-1	10782-110G8	28.59	6.25	6.40	2.50	0.78	0.47	0.62	0.31	0.47	0.31
liposarcoma cell line:SW 872	10726-110A6	50.44	14.38	6.82	4.63	1.22	0.85	0.49	0.73	0.61	0.73
liver, adult, pool1	10018-101C9	38.25	2.59	6.00	2.59	0.65	0.00	0.32	0.97	0.49	0.16
liver, fetal, pool1	10086-102B5	4.70	0.94	1.88	0.94	0.00	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	119.72	46.66	26.25	8.17	3.06	2.62	1.17	1.90	5.10	2.33
locus coeruleus, adult, donor10252	10165-103B3	204.67	59.61	15.87	6.64	4.43	5.54	3.69	2.77	4.61	1.85
locus coeruleus, adult, donor10258	10375-105G6	99.88	39.22	20.03	7.05	4.51	12.13	14.67	7.34	5.92	1.41
locus coeruleus, newborn, donor10223	10362-105F2	90.43	36.17	18.09	4.21	4.21	5.47	5.05	3.79	5.05	2.94
lung adenocarcinoma cell line:A549	10499-107C4	33.21	2.49	2.35	1.11	0.14	0.00	0.42	0.28	0.00	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	25.51	0.69	17.24	3.45	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	25.97	3.69	3.82	1.85	1.85	0.40	0.26	0.40	0.26	0.26
lung, adult, pool1	10019-101D1	44.18	3.07	5.55	1.30	0.24	0.24	0.59	1.06	0.12	0.95
lung, fetal, donor1	10068-101I5	82.48	8.56	7.42	2.28	1.71	0.86	0.86	1.43	0.57	0.57
lung, right lower lobe, adult, donor1	10075-102A3	29.78	3.21	7.33	2.29	0.46	1.37	1.83	0.46	0.92	0.92
lymph node, adult, donor1	10077-102A5	15.62	1.89	4.26	1.42	0.47	0.00	1.42	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	21.04	1.10	2.41	0.66	0.22	0.00	0.00	0.00	0.22	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	28.83	2.57	8.45	4.23	0.15	0.15	0.45	0.91	0.00	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	27.18	11.04	3.40	1.70	0.00	0.85	0.85	1.70	0.00	0.00
mature adipocyte, donor1	12231-129F8	29.30	1.33	7.10	2.22	0.00	0.00	0.00	0.00	0.00	0.44
mature adipocyte, donor2	12232-129F9	26.36	2.08	4.15	3.11	0.00	0.00	0.42	0.62	0.42	0.21
mature adipocyte, donor3	12233-129G1	23.71	0.71	4.03	1.66	0.24	0.00	0.00	0.47	0.00	0.00
mature adipocyte, donor4	12234-129G2	25.53	1.58	3.95	1.84	0.00	0.00	0.00	0.53	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	59.33	6.19	5.72	2.62	0.48	0.71	0.95	0.48	1.19	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	164.69	130.85	32.71	12.41	27.07	21.43	9.02	5.64	9.02	5.64
medial frontal gyrus, adult, donor10252	10150-102I6	259.86	93.24	23.36	6.07	11.03	9.01	3.68	3.68	11.22	1.29
medial frontal gyrus, adult, donor10258	10368-105F8	106.43	79.74	23.83	7.31	20.33	9.21	7.62	4.77	2.86	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	149.70	106.20	33.27	8.10	28.57	12.37	14.93	8.10	11.52	2.99
medial temporal gyrus - adult, donor10196	10183-103D3	209.42	109.18	37.13	10.80	26.49	39.83	31.39	21.77	26.33	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	263.37	85.53	21.43	5.09	13.37	7.22	1.27	3.82	9.97	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	38.53	75.12	40.45	3.85	19.26	11.56	7.71	1.93	3.85	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	387.55	244.01	14.35	0.00	14.35	71.77	71.77	14.35	28.71	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	124.19	86.86	41.28	6.82	30.87	5.38	1.44	3.95	5.03	2.51
medulla oblongata - adult, donor10196	10174-103C3	90.86	40.24	15.58	11.03	2.60	3.89	0.65	0.65	0.65	2.60
medulla oblongata, adult, donor10252	10155-103A2	208.52	43.35	19.35	8.20	3.87	5.42	2.63	1.86	4.80	1.39
medulla oblongata, adult, pool1	10038-101F2	258.68	87.99	28.16	10.77	8.49	2.04	1.63	4.08	1.47	3.10
medulla oblongata, newborn, donor10223	10361-105F1	100.68	34.02	18.75	4.86	5.21	5.21	2.78	4.17	3.12	2.78
medulloblastoma cell line:D283 Med	10838-111E1	55.57	9.08	3.32	3.10	0.00	1.55	2.66	0.89	1.55	0.00
medulloblastoma cell line:ONS-76	10759-110E3	32.52	16.14	6.85	1.59	0.86	0.24	0.12	0.37	0.24	0.37
melanoma cell line:COLO 679	10514-107E1	24.44	9.77	2.16	1.15	1.01	0.14	0.14	0.43	0.72	0.14
melanoma cell line:G-361	10465-106H6	36.92	9.50	4.89	1.63	0.27	1.36	1.36	1.63	0.54	0.00
meningioma cell line:HKBMM	10691-109F7	64.94	11.94	5.79	3.26	0.72	2.71	4.70	1.81	3.26	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	98.69	46.70	21.15	9.69	7.05	12.34	4.41	5.29	2.64	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	115.10	60.40	19.44	16.07	5.44	3.37	2.07	3.11	3.37	2.07
mesenchymal precursor cell - adipose, donor1	11747-123G1	24.55	6.75	10.43	2.30	2.30	0.15	0.92	0.15	0.46	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	22.54	8.36	4.36	0.91	1.64	0.36	0.91	0.00	0.55	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.42	7.04	8.28	0.83	1.66	0.41	0.00	0.41	0.83	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	27.11	5.48	4.07	1.55	0.56	0.28	0.84	0.28	0.14	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	20.03	7.51	5.39	1.73	0.39	1.35	1.54	0.77	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	18.05	7.63	5.55	3.47	4.16	0.69	0.69	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	30.04	7.21	6.35	3.78	0.51	1.03	2.23	0.69	0.86	1.54
mesenchymal precursor cell - cardiac, donor2	11753-123G7	21.05	8.28	5.41	2.07	0.69	1.04	0.58	0.23	0.35	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	31.04	7.83	8.75	3.71	1.99	1.33	1.72	0.53	0.66	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	36.33	17.02	11.88	4.19	1.49	0.54	1.35	0.81	0.41	1.62
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	34.71	13.80	11.95	6.40	0.85	1.00	1.42	1.56	0.43	2.13
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	30.63	9.22	7.58	1.98	0.99	0.99	1.98	0.66	0.99	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	32.38	11.21	8.44	3.32	1.11	0.28	0.69	0.42	0.69	1.38
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	31.77	11.52	15.71	4.54	3.14	2.09	2.09	0.35	0.70	1.75
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	34.30	18.99	7.15	2.86	2.86	1.22	1.02	1.43	0.82	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	29.48	13.30	15.10	4.67	3.59	1.44	0.72	1.44	1.08	3.24
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	29.90	9.00	4.55	2.79	1.34	0.93	0.83	0.21	0.52	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	19.84	9.12	11.40	2.28	1.37	1.60	0.91	0.91	0.68	2.05
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	42.79	28.11	11.75	3.78	2.52	1.26	2.52	0.42	1.26	3.78
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	30.04	11.66	8.97	3.44	1.34	0.75	0.45	0.45	0.75	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	27.48	10.15	8.67	2.71	1.58	0.88	1.05	0.53	0.18	1.58
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	34.24	11.04	5.15	4.42	2.21	1.10	2.21	0.74	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	33.19	16.88	14.59	3.72	2.58	1.43	1.14	0.57	1.72	2.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	29.89	12.21	11.79	2.11	2.53	2.11	2.53	1.26	2.11	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	16.90	5.94	7.31	1.37	0.00	0.91	1.37	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	16.11	6.65	6.14	1.53	1.02	0.77	1.02	0.00	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	17.80	8.38	7.33	1.31	2.88	1.57	1.31	0.00	0.26	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	13.25	4.93	7.70	0.92	1.54	0.92	1.23	0.31	0.31	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	15.53	6.35	4.00	1.41	1.88	0.71	1.88	0.47	0.71	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	15.23	3.72	5.75	1.02	0.34	0.34	0.68	0.00	0.00	1.69
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	14.54	5.50	7.07	1.57	0.79	1.18	2.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	14.83	3.24	6.02	0.46	0.46	0.46	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	17.88	7.21	6.06	1.44	1.44	0.29	0.29	0.29	0.87	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	12.94	5.80	7.36	1.56	0.89	0.45	1.34	0.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	20.19	6.73	5.53	2.16	1.68	1.20	0.72	0.24	0.72	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	16.13	6.60	8.80	0.73	0.00	0.00	1.47	1.47	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	14.43	6.38	5.71	0.67	0.67	0.34	0.34	0.67	1.01	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.69	5.73	9.01	3.28	0.82	0.82	0.82	0.82	1.23	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.88	4.73	7.73	0.86	0.86	1.29	0.00	0.86	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	8.20	2.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	5.16	0.00	5.16	0.00	0.00	0.00	0.00	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	16.89	6.17	5.85	0.97	1.62	0.65	0.32	0.65	0.32	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	18.91	8.73	5.82	1.45	0.00	1.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	14.39	4.80	8.00	0.00	1.07	1.07	1.07	0.53	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	17.99	4.91	6.54	0.00	0.00	2.45	0.00	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	15.16	5.44	4.66	1.94	1.17	0.00	1.17	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	10.49	2.10	8.39	0.00	0.00	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	12.92	3.97	4.97	1.99	2.98	0.99	0.00	1.99	0.00	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	14.30	0.00	4.77	0.00	0.00	0.00	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	11.27	4.74	8.89	1.78	0.00	0.59	1.19	0.59	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	0.00	6.09	0.00	0.00	2.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	13.93	8.23	2.53	1.27	0.63	0.63	0.63	0.00	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	12.76	3.10	3.79	1.03	0.34	0.00	0.69	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	0.00	2.15	2.15	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	7.98	0.00	0.00	0.00	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	0.00	6.89	0.00	3.44	0.00	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.04	2.04	4.07	1.63	1.22	1.63	1.22	0.41	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	12.71	2.38	2.38	0.00	0.00	0.00	0.00	0.79	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.69	2.95	0.59	0.00	1.18	0.00	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	12.16	3.12	1.56	1.25	0.31	0.94	0.31	0.31	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	14.70	2.67	2.67	0.00	0.00	0.00	1.34	0.00	1.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	13.01	7.10	4.73	0.00	0.00	0.00	0.00	1.18	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	0.00	2.57	0.00	0.00	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	19.96	3.44	2.75	0.00	1.38	0.00	0.69	1.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	19.30	2.97	3.96	1.98	0.00	0.99	0.00	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	12.34	3.36	2.24	1.12	0.00	0.00	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	17.81	0.64	2.54	1.27	1.91	0.00	1.27	1.27	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	8.46	2.01	2.01	1.21	0.00	2.01	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	2.18	4.36	2.18	0.00	0.00	0.00	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	12.67	0.00	5.07	0.00	0.00	0.00	2.53	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	10.32	1.21	3.64	1.82	0.00	0.61	0.00	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	9.04	4.52	0.00	0.00	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	7.41	1.65	2.47	0.00	0.00	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	9.52	2.58	4.37	0.99	0.40	0.40	0.00	0.20	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	11.36	2.60	3.89	1.95	0.65	0.65	0.32	1.62	0.65	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	12.22	2.04	6.11	1.02	1.02	0.00	0.00	2.04	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	43.33	13.15	17.80	2.32	2.32	0.00	0.00	0.00	0.00	3.87
mesothelioma cell line:ACC-MESO-1	10493-107B7	64.26	10.87	9.21	7.09	0.24	0.94	0.24	1.18	0.71	1.42
mesothelioma cell line:ACC-MESO-4	10494-107B8	22.24	8.11	6.26	1.39	1.16	0.93	0.93	0.23	0.46	1.85
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	47.01	4.27	4.27	4.27	8.55	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	18.39	9.97	5.75	2.16	0.82	0.82	0.92	0.72	0.21	0.51
mesothelioma cell line:Mero-25	10850-111F4	24.28	12.26	9.31	2.72	0.23	1.59	0.45	1.13	0.68	2.04
mesothelioma cell line:Mero-41	10851-111F5	30.31	6.11	7.33	2.20	1.47	0.73	2.20	0.49	0.24	1.47
mesothelioma cell line:Mero-48a	10852-111F6	18.38	7.53	6.20	1.55	0.44	0.89	0.89	0.44	0.66	0.66
mesothelioma cell line:Mero-82	10853-111F7	16.56	11.83	5.78	1.58	1.05	0.79	0.26	0.53	1.05	0.79
mesothelioma cell line:Mero-83	10854-111F8	16.68	10.04	6.30	2.89	1.53	0.68	1.19	0.34	0.85	0.68
mesothelioma cell line:Mero-84	10855-111F9	14.66	3.29	3.79	1.77	0.25	1.26	0.25	0.25	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	15.94	5.80	5.18	0.83	1.04	1.04	0.62	0.41	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	29.82	13.42	9.11	3.15	0.83	1.66	1.16	0.66	0.66	0.83
mesothelioma cell line:NCI-H226	10846-111E9	15.57	7.78	8.87	3.44	0.72	0.72	0.72	0.54	0.00	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	10.42	3.42	5.12	1.54	0.51	0.34	0.68	0.00	0.00	0.68
mesothelioma cell line:NCI-H28	10845-111E8	27.74	9.67	15.27	1.53	0.51	1.78	1.53	0.25	1.02	0.51
mesothelioma cell line:No36	10857-111G2	33.27	8.48	15.01	6.20	0.33	0.98	0.65	1.63	0.33	0.65
mesothelioma cell line:ONE58	10858-111G3	31.16	12.46	13.82	4.61	0.81	1.63	0.81	0.81	0.54	0.27
migratory langerhans cells, donor1	11901-125F2	53.16	6.91	7.87	2.49	1.73	1.15	2.49	1.15	0.19	0.38
migratory langerhans cells, donor2	11902-125F3	49.33	10.01	6.84	2.81	1.71	1.10	1.34	1.10	0.61	0.85
migratory langerhans cells, donor3	11903-125F4	45.41	7.00	5.92	2.33	1.62	0.54	0.90	0.18	0.18	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	53.54	9.14	6.20	6.86	0.00	4.24	5.55	1.96	3.92	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	12.93	2.97	1.06	0.42	0.00	0.00	0.64	0.21	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	23.04	4.61	4.84	1.84	0.00	0.23	0.00	0.23	0.46	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	33.11	4.57	7.80	0.76	0.76	0.76	0.57	0.57	0.00	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	26.24	2.77	5.73	2.22	0.37	0.55	0.74	0.55	0.37	0.55
myeloma cell line:PCM6	10474-106I6	27.08	3.95	1.98	2.17	0.00	0.40	0.40	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	23.84	6.59	4.57	1.52	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	17.26	10.79	6.47	1.18	2.55	0.20	0.00	0.78	0.20	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	32.20	3.57	3.79	1.00	0.11	0.11	0.00	0.67	0.11	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	25.37	1.76	3.16	1.54	0.00	0.37	0.81	0.59	0.22	0.37
nasal epithelial cells, donor2	12227-129F4	30.91	3.86	2.76	0.55	0.00	1.10	0.00	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	127.45	24.85	6.44	2.30	2.30	1.15	0.92	1.84	0.46	0.23
neuroblastoma cell line:NB-1	10539-107G8	177.54	67.91	28.81	13.10	5.43	1.68	1.68	3.37	1.87	2.06
neuroblastoma cell line:NBsusSR	10607-108F4	63.06	22.78	4.43	3.59	1.48	1.48	2.32	1.48	0.84	0.00
neuroblastoma cell line:NH-12	10555-107I6	108.27	24.41	8.01	2.42	0.56	2.61	1.68	1.68	1.49	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	51.24	11.15	5.93	2.14	0.00	3.08	1.90	1.19	2.14	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	30.57	5.07	7.92	2.38	0.32	1.58	1.11	0.48	0.95	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	41.06	3.62	5.43	4.43	0.00	1.01	1.01	0.40	0.81	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	12.08	2.54	5.72	1.91	0.00	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	21.56	8.52	10.11	2.66	0.80	0.53	0.00	1.06	0.80	1.86
neutrophil PMN, donor1	12133-128D9	59.50	0.00	29.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	122.78	8.46	15.22	5.75	0.51	1.18	1.86	1.18	1.52	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	102.46	48.83	37.62	6.40	12.81	0.80	0.80	1.60	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	30.46	4.81	8.66	3.21	0.64	0.96	0.32	1.60	0.64	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	28.90	13.66	10.25	3.42	1.05	2.10	2.36	0.53	0.79	1.58
nucleus accumbens, adult, pool1	10037-101F1	331.74	153.45	44.24	10.31	33.18	3.66	2.25	8.44	1.97	3.09
occipital cortex - adult, donor10196	10172-103C1	131.86	80.35	24.72	6.18	12.36	8.24	0.00	4.12	12.36	2.06
occipital cortex, adult, donor10252	10163-103B1	236.96	53.40	12.88	6.17	11.54	6.44	3.76	1.61	9.12	0.27
occipital cortex, newborn, donor10223	10355-105E4	154.68	86.98	37.85	8.73	28.39	4.37	2.18	4.37	5.46	2.55
occipital lobe, adult, donor1	10076-102A4	224.35	90.00	35.16	12.07	21.52	22.83	3.94	13.38	5.51	3.41
occipital lobe, fetal, donor1	10073-102A1	174.21	97.41	25.32	8.58	15.45	17.16	19.74	6.87	9.01	1.29
occipital pole, adult, pool1	10036-101E9	370.24	163.75	36.58	10.64	42.10	4.02	2.84	9.93	2.37	2.44
olfactory region, adult	10195-103E6	193.73	107.75	32.29	8.60	16.62	7.83	4.78	2.48	6.30	2.67
optic nerve, donor1	10277-104E7	152.08	32.02	32.02	6.00	2.00	2.00	4.00	0.00	0.00	6.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	41.69	7.18	12.99	4.56	0.11	0.57	0.57	0.57	0.68	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	37.23	3.57	4.40	1.37	0.14	0.14	0.14	0.82	0.14	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	29.80	2.20	3.22	1.52	0.00	1.52	1.52	0.51	0.85	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	11.44	1.62	2.77	1.39	0.35	0.23	0.23	0.35	0.23	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	33.51	8.82	6.76	1.47	1.76	0.29	0.29	0.88	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	102.78	10.28	22.42	3.74	0.00	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	17.60	9.12	7.85	3.61	2.97	0.21	0.21	0.42	0.00	0.85
ovary, adult, pool1	10020-101D2	66.91	8.74	4.28	1.83	0.35	0.79	0.52	0.87	0.79	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	17.60	6.23	2.57	3.30	0.55	0.55	0.73	0.55	0.55	0.18
pancreas, adult, donor1	10049-101G4	36.68	0.94	4.70	2.82	0.00	0.94	0.94	0.00	3.76	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	26.00	1.40	6.15	4.19	0.00	1.40	0.56	1.12	0.56	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	47.70	14.14	20.27	5.11	2.73	4.60	4.09	1.36	2.21	2.90
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	33.45	3.81	1.82	1.66	0.50	0.33	0.50	0.33	0.50	0.17
paracentral gyrus, adult, pool1	10035-101E8	358.67	176.36	40.45	13.00	44.30	3.94	3.57	9.43	2.93	3.84
parietal cortex, adult, donor10258	10373-105G4	110.84	58.72	18.35	1.47	14.68	2.20	2.94	3.67	5.14	1.47
parietal lobe - adult, donor10196	10171-103B9	156.12	90.29	20.69	5.64	12.23	4.70	4.70	5.64	8.46	0.94
parietal lobe, adult, donor10252	10157-103A4	267.65	85.23	21.38	5.42	16.82	8.27	3.71	4.28	11.40	0.86
parietal lobe, adult, pool1	10034-101E7	369.49	164.08	42.47	11.54	38.42	2.03	3.35	8.37	2.56	2.73
parietal lobe, fetal, donor1	10072-101I9	176.51	108.62	31.03	2.91	11.64	20.37	14.55	6.79	11.64	0.97
parietal lobe, newborn, donor10223	10356-105E5	135.34	77.02	38.51	9.35	34.40	6.73	4.49	8.60	7.48	3.36
parotid gland, adult	10199-103F1	37.00	1.23	1.85	1.85	0.00	1.23	1.85	0.00	0.00	0.00
penis, adult	10200-103F2	44.04	4.30	6.45	3.22	1.07	1.61	1.07	0.00	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	45.93	10.60	5.21	2.23	0.19	1.67	2.42	0.74	0.56	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	27.97	1.75	3.50	2.19	0.15	0.44	0.58	0.73	0.73	0.15
pineal gland - adult, donor10196	10179-103C8	100.62	22.58	3.87	2.58	0.65	3.87	0.65	1.29	1.94	0.00
pineal gland, adult, donor10252	10160-103A7	171.15	21.91	11.84	5.33	0.59	0.59	1.18	1.18	1.18	0.00
pineal gland, adult, donor10258	10377-105G8	87.16	20.07	10.03	4.39	0.00	1.88	3.14	1.25	1.25	0.63
pituitary gland - adult, donor10196	10180-103C9	117.37	42.50	15.18	3.04	2.02	1.01	10.12	1.01	4.05	0.00
pituitary gland, adult, donor10252	10162-103A9	214.73	36.48	11.99	9.90	3.13	4.69	1.56	3.13	2.08	2.08
pituitary gland, adult, donor10258	10378-105G9	97.04	23.83	5.96	6.81	0.85	1.70	2.55	0.85	1.70	0.85
placenta, adult, pool1	10021-101D3	53.43	6.02	4.73	2.90	0.65	0.54	0.65	0.54	0.54	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	23.04	4.50	5.03	1.99	0.13	1.06	0.93	0.40	0.26	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	51.21	11.21	9.96	1.71	3.58	0.78	1.25	0.31	0.16	0.47
pons, adult, pool1	10033-101E6	287.72	129.96	42.78	16.96	23.24	3.36	2.15	8.43	1.55	4.99
postcentral gyrus, adult, pool1	10032-101E5	376.51	159.62	44.55	12.90	41.06	5.23	4.01	10.29	3.49	2.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	16.73	0.00	12.55	4.18	0.00	0.00	0.00	0.00	0.00	2.09
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	17.33	2.77	1.60	2.18	0.44	0.29	1.17	0.73	0.29	0.15
prostate cancer cell line:PC-3	10439-106E7	38.66	8.35	7.44	1.82	0.54	0.91	0.73	0.91	0.91	0.54
prostate, adult, pool1	10022-101D4	48.43	5.99	6.08	2.09	0.91	0.54	0.45	0.91	0.45	0.09
putamen, adult, donor10196	10176-103C5	347.72	122.04	33.99	6.14	7.79	8.50	5.19	4.49	12.04	1.89
putamen, adult, donor10252	10152-102I8	129.41	37.25	19.61	7.84	7.84	1.96	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	55.73	33.88	19.67	4.37	0.00	4.37	1.09	2.19	1.09	5.46
putamen, adult, donor10258, tech_rep2	10372-105G3	211.89	70.07	27.30	7.25	3.87	4.35	4.11	2.66	3.87	1.21
putamen, newborn, donor10223	10365-105F5	70.47	23.99	14.99	3.00	6.00	6.75	6.75	5.25	6.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	27.64	4.65	3.78	2.33	0.00	0.00	0.00	0.29	0.00	0.29
rectum, fetal, donor1	10067-101I4	50.08	19.47	15.30	1.39	0.00	1.39	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	38.16	5.94	8.06	2.12	0.64	1.91	1.48	0.85	0.42	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	144.97	7.04	9.94	4.14	1.24	5.38	5.80	1.66	3.31	0.00
retina, adult, pool1	10030-101E3	105.07	12.13	5.27	2.09	1.89	2.29	1.29	1.69	1.19	0.20
retinoblastoma cell line:Y79	10475-106I7	109.38	15.85	10.39	5.72	1.82	2.60	2.34	1.82	0.78	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	54.10	17.70	7.50	3.07	1.60	0.86	0.49	0.49	0.49	0.98
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	43.59	5.62	8.72	3.09	0.28	0.00	0.56	0.56	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	32.59	7.58	6.82	3.03	2.27	0.00	0.76	0.00	2.27	2.27
salivary acinar cells, donor1	11771-123I7	21.20	2.27	2.75	1.13	0.65	0.32	0.81	0.65	0.16	0.16
salivary acinar cells, donor2	11772-123I8	23.96	2.34	3.58	1.79	0.55	0.96	1.38	0.00	1.24	0.14
salivary acinar cells, donor3	11773-123I9	27.81	1.32	9.27	2.65	0.00	0.66	0.00	0.00	1.99	0.66
salivary gland, adult, pool1	10093-102C3	33.17	1.72	1.14	1.14	0.00	0.57	1.72	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	36.59	5.40	7.59	2.36	0.84	0.59	0.59	1.01	0.42	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	32.91	6.70	7.99	3.17	0.24	0.35	0.35	0.59	0.24	0.71
seminal vesicle, adult	10201-103F3	37.56	2.12	5.82	1.06	1.06	3.70	2.12	1.59	1.59	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	32.55	7.29	7.29	3.40	0.97	1.70	0.97	2.19	1.46	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	16.10	3.52	4.78	2.52	0.50	0.50	1.51	0.50	0.75	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	15.05	6.02	9.03	3.01	0.00	0.00	3.01	0.00	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	42.18	15.85	10.48	4.97	1.34	0.67	0.81	1.34	0.40	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	44.43	3.32	10.72	3.76	0.44	0.22	0.88	0.44	0.55	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	20.13	1.94	6.84	1.55	0.13	0.26	0.00	0.26	0.00	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	30.50	4.26	4.97	0.00	0.00	0.71	0.71	0.71	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	33.58	1.68	2.64	1.68	0.12	0.36	0.24	0.36	0.00	0.12
skeletal muscle, fetal, donor1	10066-101I3	22.11	2.01	5.03	1.01	0.00	1.01	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	27.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	34.72	1.89	6.31	1.89	0.63	1.26	0.63	1.89	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	109.40	36.35	28.68	9.67	6.00	2.00	1.00	1.33	1.33	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	130.18	41.61	11.98	5.04	2.84	9.14	5.04	1.58	4.73	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	60.52	12.14	3.66	3.47	0.39	0.96	1.16	0.39	1.16	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	24.56	3.63	13.85	3.46	0.16	0.16	0.49	1.48	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	98.76	6.43	7.08	4.66	0.16	4.34	2.90	2.09	2.09	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	81.28	36.61	5.23	3.70	6.10	2.18	0.65	1.96	0.65	0.22
small intestine, adult, pool1	10024-101D6	44.91	4.90	9.32	2.87	0.48	0.48	0.36	0.36	0.48	0.12
small intestine, fetal, donor1	10064-101I1	29.24	3.19	3.44	1.23	0.25	1.47	2.21	0.25	1.23	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	97.45	13.34	27.70	4.62	1.54	4.10	8.21	2.56	3.08	1.03
smooth muscle, adult, pool1	10048-101G3	42.13	2.58	3.88	1.03	0.78	1.03	1.55	0.78	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	72.37	7.24	25.73	5.09	0.80	0.27	0.54	1.07	0.54	3.48
spinal cord - adult, donor10196	10181-103D1	108.28	40.60	19.96	5.74	2.98	7.57	4.13	2.52	9.86	2.29
spinal cord, adult, donor10252	10159-103A6	161.65	26.81	14.98	4.73	3.94	2.76	2.76	0.79	2.37	0.39
spinal cord, adult, donor10258	10369-105F9	65.03	39.43	13.84	6.23	6.23	3.46	10.38	4.15	2.08	0.69
spinal cord, fetal, donor1	10056-101H2	192.10	64.64	24.39	12.20	6.71	10.98	1.83	3.05	4.27	3.66
spinal cord, newborn, donor10223	10359-105E8	105.62	37.66	18.37	9.64	2.76	4.13	7.35	3.21	6.89	3.67
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	40.48	13.44	13.44	3.58	1.05	1.05	0.45	1.05	0.30	1.49
spleen, adult, pool1	10025-101D7	34.03	3.63	4.96	2.09	0.22	0.11	0.77	0.88	0.55	0.55
spleen, fetal, pool1	10044-101F8	52.20	5.40	5.80	1.99	0.64	0.79	0.56	0.95	0.40	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	24.95	1.97	3.21	1.04	0.31	0.41	0.41	0.72	0.10	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	33.80	3.42	1.90	2.09	0.00	0.95	0.00	0.00	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	34.60	2.80	3.49	1.40	0.35	3.49	1.75	0.70	3.15	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	56.69	8.60	3.91	2.74	0.00	0.39	0.39	1.17	1.95	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	43.56	3.04	7.20	2.59	0.11	0.68	0.45	0.56	0.23	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	31.77	5.08	5.93	1.27	0.00	1.69	2.12	0.00	1.69	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	28.77	7.19	12.69	2.54	1.27	0.85	0.42	0.00	0.42	0.42
stomach, fetal, donor1	10062-101H8	38.45	1.07	9.61	2.14	1.07	0.00	2.14	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	39.31	2.28	3.42	3.42	0.00	2.85	0.57	0.57	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	54.27	0.00	54.27	0.00	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	218.92	24.09	11.63	3.95	1.66	8.10	4.15	1.25	3.74	0.42
substantia nigra, adult, donor10258	10371-105G2	65.17	66.73	17.59	8.28	8.28	4.14	4.66	4.14	5.17	1.55
substantia nigra, newborn, donor10223	10358-105E7	50.17	17.66	19.78	4.24	4.95	3.53	2.12	0.00	2.83	2.83
synovial sarcoma cell line:HS-SY-II	10441-106E9	48.60	19.26	6.65	5.04	0.92	1.15	0.23	1.83	0.46	0.00
temporal lobe, adult, pool1	10031-101E4	392.40	174.63	48.91	15.60	48.15	6.44	5.76	11.27	5.00	3.39
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	279.21	169.52	29.20	6.41	11.40	22.08	7.12	5.70	9.97	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	241.31	148.56	35.16	5.71	16.70	14.94	5.71	9.23	7.91	0.88
tenocyte, donor1	11763-123H8	37.70	12.22	11.87	1.40	1.75	3.14	3.14	1.05	1.05	0.00
tenocyte, donor2	11765-123I1	24.80	8.01	7.25	1.91	3.05	1.53	0.00	0.76	1.53	1.14
tenocyte, donor3	11768-123I4	20.39	7.78	12.97	2.59	0.37	1.11	1.11	0.74	0.37	2.22
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	68.49	13.60	7.31	6.29	0.68	2.89	1.70	0.34	1.02	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	65.36	22.35	7.71	8.48	2.31	1.70	2.93	1.23	1.39	1.08
teratocarcinoma cell line:PA-1	10807-111A6	36.88	8.37	5.58	4.96	0.31	0.77	0.62	0.31	1.08	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	35.55	8.12	9.39	5.84	0.38	0.25	0.76	0.25	0.13	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	48.03	16.64	9.08	5.29	0.76	1.51	3.40	0.00	1.89	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	57.15	15.27	6.76	3.93	0.33	1.31	0.87	0.55	0.55	0.55
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	30.29	2.28	6.19	1.95	0.00	2.93	1.63	0.98	0.65	0.65
testis, adult, pool1	10026-101D8	62.38	9.99	5.26	4.19	0.64	1.07	1.18	2.36	0.64	0.00
testis, adult, pool2	10096-102C6	48.72	13.53	9.47	8.57	0.90	3.16	1.35	0.90	1.35	0.00
thalamus - adult, donor10196	10168-103B6	113.71	51.89	20.98	4.42	2.21	6.62	2.21	2.21	7.73	0.00
thalamus, adult, donor10252	10154-103A1	241.30	28.91	15.32	5.31	4.06	5.94	2.50	3.59	4.84	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	52.35	46.19	33.87	1.54	4.62	12.32	1.54	9.24	6.16	7.70
thalamus, adult, donor10258, tech_rep2	10370-105G1	82.34	26.84	15.65	4.61	4.12	5.27	8.40	5.43	3.46	1.98
thalamus, newborn, donor10223	10366-105F6	60.98	55.23	42.00	7.48	9.78	3.45	2.88	1.15	5.18	1.73
throat, adult	10209-103G2	45.44	3.00	7.24	1.25	0.75	1.50	1.25	0.25	1.25	0.25
throat, fetal, donor1	10061-101H7	29.25	1.52	2.13	1.52	0.91	0.91	2.44	0.30	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	49.48	10.33	6.76	2.78	1.79	0.60	0.60	0.99	1.59	0.40
thymus, adult, pool1	10027-101D9	44.24	3.18	4.27	1.79	0.10	0.40	0.40	0.80	0.20	0.10
thymus, fetal, pool1	10043-101F7	67.23	4.57	4.99	2.91	0.21	1.04	0.94	0.83	0.31	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	28.19	8.11	9.31	3.72	1.20	1.06	3.06	0.40	0.93	1.20
thyroid carcinoma cell line:TCO-1	10783-110G9	39.39	7.12	9.36	4.05	1.26	0.98	0.28	0.56	0.14	0.70
thyroid, adult, pool1	10028-101E1	48.71	2.61	4.01	1.31	0.65	0.47	0.75	0.47	0.19	0.09
thyroid, fetal, donor1	10060-101H6	30.58	3.16	3.95	0.53	0.53	0.79	1.05	0.53	1.05	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	36.96	0.00	3.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	32.33	1.40	3.72	2.09	0.70	1.86	1.16	1.40	0.70	0.23
tongue, fetal, donor1	10059-101H5	35.07	1.18	2.36	1.97	0.39	1.58	1.58	0.00	0.39	0.00
tonsil, adult, pool1	10047-101G2	43.88	3.31	5.51	2.30	0.30	0.70	0.10	0.20	0.00	0.30
trachea, adult, pool1	10029-101E2	43.35	4.91	5.64	0.98	0.82	0.65	0.16	0.41	0.49	0.41
trachea, fetal, donor1	10058-101H4	34.62	5.77	2.69	1.92	1.15	1.92	0.77	1.54	1.15	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	23.74	5.31	14.88	3.54	0.71	0.35	1.42	1.06	0.35	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	53.29	11.65	9.73	6.38	1.32	0.71	1.11	0.61	0.20	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	43.56	9.56	7.05	3.76	0.47	0.31	1.25	1.10	0.63	0.47
tridermal teratoma cell line:HGRT	10694-109G1	28.54	1.90	7.61	1.90	0.00	0.00	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	35.98	4.23	9.40	3.64	0.51	1.19	0.59	0.34	0.25	0.51
umbilical cord, fetal, donor1	10057-101H3	35.47	6.26	8.35	2.09	2.09	0.00	4.17	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	55.28	6.31	3.24	1.02	0.51	0.68	0.68	1.37	0.85	0.00
uterus, fetal, donor1	10055-101H1	47.61	6.14	3.58	1.02	0.51	1.02	0.51	0.51	1.02	0.00
vagina, adult	10204-103F6	36.19	3.88	7.11	1.29	0.65	1.94	0.65	0.65	0.65	0.00
vein, adult	10191-103E2	42.74	3.29	3.73	1.10	0.44	2.63	1.75	0.22	1.53	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	26.70	0.80	1.60	1.07	0.27	0.00	0.27	0.00	0.00	0.00